<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, CA USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26716990</article-id>
      <article-id pub-id-type="pmc">4696675</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0146035</article-id>
      <article-id pub-id-type="publisher-id">PONE-D-15-44333</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Single Amino Acid Deletion (&#x394;F1502) in the S6 Segment of Ca<sub>V</sub>2.1 Domain III Associated with Congenital Ataxia Increases Channel Activity and Promotes Ca<sup>2+</sup> Influx</article-title>
        <alt-title alt-title-type="running-head">Ca<sub>V</sub>2.1 Gain-Of-Function and Congenital Ataxia</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Bahamonde</surname>
            <given-names>Maria Isabel</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Serra</surname>
            <given-names>Selma Ang&#xE8;lica</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Drechsel</surname>
            <given-names>Oliver</given-names>
          </name>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rahman</surname>
            <given-names>Rubayte</given-names>
          </name>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marc&#xE9;-Grau</surname>
            <given-names>Anna</given-names>
          </name>
          <xref ref-type="aff" rid="aff004">
            <sup>4</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Prieto</surname>
            <given-names>Marta</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ossowski</surname>
            <given-names>Stephan</given-names>
          </name>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Macaya</surname>
            <given-names>Alfons</given-names>
          </name>
          <xref ref-type="aff" rid="aff004">
            <sup>4</sup>
          </xref>
          <xref ref-type="author-notes" rid="econtrib001">
            <sup>&#x2021;</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fern&#xE1;ndez-Fern&#xE1;ndez</surname>
            <given-names>Jos&#xE9; M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref ref-type="author-notes" rid="econtrib001">
            <sup>&#x2021;</sup>
          </xref>
          <xref rid="cor001" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="aff001">
        <label>1</label>
        <addr-line>Laboratori de Fisiologia Molecular i Canalopaties, Departament de Ci&#xE8;ncies Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain</addr-line>
      </aff>
      <aff id="aff002">
        <label>2</label>
        <addr-line>Genomic and Epigenomic Variation in Disease Group, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain</addr-line>
      </aff>
      <aff id="aff003">
        <label>3</label>
        <addr-line>Universitat Pompeu Fabra, Barcelona, Spain</addr-line>
      </aff>
      <aff id="aff004">
        <label>4</label>
        <addr-line>Pediatric Neurology Research Group, Vall d&#x2019;Hebron Research Institute, Universitat Aut&#xF2;noma de Barcelona, Barcelona, Spain</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Barnes</surname>
            <given-names>Steven</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>Dalhousie University, CANADA</addr-line>
      </aff>
      <author-notes>
        <fn fn-type="conflict" id="coi001">
          <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
        </fn>
        <fn fn-type="con" id="contrib001">
          <p>Conceived and designed the experiments: SO AM JMF-F. Performed the experiments: MIB SAS OD RR AM-G MP SO AM JMF-F. Analyzed the data: MIB SAS OD RR AM-G MP SO AM JMF-F. Wrote the paper: MIB SAS OD RR AM-G MP SO AM JMF-F. Led the study, wrote and finalized the manuscript: JMF-F.</p>
        </fn>
        <fn fn-type="other" id="econtrib001">
          <p>&#x2021; AM and JMF-F are joint senior authors on this work.</p>
        </fn>
        <corresp id="cor001">* E-mail: <email>jmanuel.fernandez@upf.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>10</volume>
      <issue>12</issue>
      <elocation-id>e0146035</elocation-id>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>10</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>11</day>
          <month>12</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 Bahamonde et al</copyright-statement>
        <copyright-year>2015</copyright-year>
        <copyright-holder>Bahamonde et al</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0146035.pdf"/>
      <abstract>
        <p>Mutations in the <italic>CACNA1A</italic> gene, encoding the pore-forming Ca<sub>V</sub>2.1 (P/Q-type) channel &#x3B1;<sub>1A</sub> subunit, result in heterogeneous human neurological disorders, including familial and sporadic hemiplegic migraine along with episodic and progressive forms of ataxia. Hemiplegic Migraine (HM) mutations induce gain-of-channel function, mainly by shifting channel activation to lower voltages, whereas ataxia mutations mostly produce loss-of-channel function. However, some HM-linked gain-of-function mutations are also associated to congenital ataxia and/or cerebellar atrophy, including the deletion of a highly conserved phenylalanine located at the S6 pore region of &#x3B1;<sub>1A</sub> domain III (&#x394;F1502). Functional studies of &#x394;F1502 Ca<sub>V</sub>2.1 channels, expressed in <italic>Xenopus</italic> oocytes, using the non-physiological Ba<sup>2+</sup> as the charge carrier have only revealed discrete alterations in channel function of unclear pathophysiological relevance. Here, we report a second case of congenital ataxia linked to the &#x394;F1502 &#x3B1;<sub>1A</sub> mutation, detected by whole-exome sequencing, and analyze its functional consequences on Ca<sub>V</sub>2.1 human channels heterologously expressed in mammalian tsA-201 HEK cells, using the physiological permeant ion Ca<sup>2+</sup>. &#x394;F1502 strongly decreases the voltage threshold for channel activation (by ~ 21 mV), allowing significantly higher Ca<sup>2+</sup> current densities in a range of depolarized voltages with physiological relevance in neurons, even though maximal Ca<sup>2+</sup> current density through &#x394;F1502 Ca<sub>V</sub>2.1 channels is 60% lower than through wild-type channels. &#x394;F1502 accelerates activation kinetics and slows deactivation kinetics of Ca<sub>V</sub>2.1 within a wide range of voltage depolarization. &#x394;F1502 also slowed Ca<sub>V</sub>2.1 inactivation kinetic and shifted the inactivation curve to hyperpolarized potentials (by ~ 28 mV). &#x394;F1502 effects on Ca<sub>V</sub>2.1 activation and deactivation properties seem to be of high physiological relevance. Thus, &#x394;F1502 strongly promotes Ca<sup>2+</sup> influx in response to either single or trains of action potential-like waveforms of different durations. Our observations support a causative role of gain-of-function Ca<sub>V</sub>2.1 mutations in congenital ataxia, a neurodevelopmental disorder at the severe-most end of <italic>CACNA1A</italic>-associated phenotypic spectrum.</p>
      </abstract>
      <funding-group>
        <funding-statement>This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2012-31089 to JMF-F; SEV-2012-0208 to Centre for Genomic Regulation, &#x201C;Centro de Excelencia Severo Ochoa 2013-2017&#x201D;; and MDM-2014-0370 through the &#x201C;Mar&#xED;a de Maeztu&#x201D; Programme for Units of Excellence in R&amp;D to &#x201C;Departament de Ci&#xE8;ncies Experimentals i de la Salut&#x201D;), FEDER Funds, Fondo de Investigaci&#xF3;n Sanitaria, Instituto Carlos III, Spain (RIC RD12/0042/0014, Red HERACLES, and Grant PI12/1005 to AM). AM-G is a predoctoral fellow supported by Vall d&#x2019;Hebron Institut de Recerca, Barcelona, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="8"/>
        <table-count count="0"/>
        <page-count count="28"/>
      </counts>
      <custom-meta-group>
        <custom-meta id="data-availability">
          <meta-name>Data Availability</meta-name>
          <meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
    <notes>
      <title>Data Availability</title>
      <p>All relevant data are within the paper and its Supporting Information files.</p>
    </notes>
  </front>
  <body>
    <sec sec-type="intro" id="sec001">
      <title>Introduction</title>
      <p>The Ca<sub>V</sub>2.1 (P/Q-type) Ca<sup>2+</sup> channel, encoded by the <italic>CACNA1A</italic> gene, is a high-voltage-activated channel composed of a main transmembrane pore-forming subunit (&#x3B1;<sub>1A</sub>), associated to a disulfide-linked &#x3B1;<sub>2</sub>&#x3B4; subunit dimer, and one or more intracellular &#x3B2; subunits (Ca<sub>V</sub>&#x3B2;<sub>1&#x2013;4</sub>). The &#x3B1;<sub>1A</sub> subunit consists of four repeated domains (I&#x2013;IV) each containing six transmembrane regions (S1&#x2013;S6) with a voltage sensor (S1&#x2013;S4) and a pore region (S5, P-loop and S6). The N- and C-terminal regions as well as the large intracellular loops between &#x3B1;<sub>1A</sub> domains serve as signalling platforms for channel gating regulation processes, which includes the functional interaction with presynaptic proteins such as SNARE proteins of the vesicle docking/fusion machinery [<xref rid="pone.0146035.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0146035.ref002" ref-type="bibr">2</xref>]. Indeed, Ca<sub>V</sub>2.1 channels are localized at presynaptic terminals [<xref rid="pone.0146035.ref003" ref-type="bibr">3</xref>] tightly coupled to neurotransmitter release [<xref rid="pone.0146035.ref001" ref-type="bibr">1</xref>]. Nevertheless, it also presents somatodendritic localization in neurons, thus contributing to the generation of postsynaptic responses, such as neuronal excitability [<xref rid="pone.0146035.ref004" ref-type="bibr">4</xref>&#x2013;<xref rid="pone.0146035.ref006" ref-type="bibr">6</xref>], gene expression [<xref rid="pone.0146035.ref007" ref-type="bibr">7</xref>], Ca<sup>2+</sup> signaling microdomains [<xref rid="pone.0146035.ref008" ref-type="bibr">8</xref>], and neuronal survival [<xref rid="pone.0146035.ref009" ref-type="bibr">9</xref>].</p>
      <p>Ca<sub>V</sub>2.1 channels are expressed in all brain areas involved in the pathogenesis of migraine, including the cerebral cortex and nociceptive pathways, and their expression is particularly high in the cerebellum (reviewed in [<xref rid="pone.0146035.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>]). Accordingly, mutations in the <italic>CACNA1A</italic> gene are linked to familial and sporadic hemiplegic migraine (FHM/SHM), and both episodic and progressive forms of ataxia (reviewed in [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>]).</p>
      <p>FHM and SHM are rare subtypes of migraine with aura that include hemiparesis during the aura phase [<xref rid="pone.0146035.ref010" ref-type="bibr">10</xref>&#x2013;<xref rid="pone.0146035.ref012" ref-type="bibr">12</xref>]. Hemiplegic Migraine (HM) mutations in the &#x3B1;<sub>1A</sub> channel subunit locate around the line pore (S5-P-S6 segments), in the loops connecting S3-S4 or S4-S5 segments and in the S1 and S4 segments of the voltage sensors [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0146035.ref014" ref-type="bibr">14</xref>]. The functional analysis of all HM <italic>CACNA1A</italic> mutations evaluated so far, both in heterologous expression systems and excitatory neurons from FHM knock-in (KI) mice, revealed an overall gain of Ca<sub>V</sub>2.1 channel function, mainly due to a reduction in the voltage threshold of channel activation [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0146035.ref015" ref-type="bibr">15</xref>&#x2013;<xref rid="pone.0146035.ref018" ref-type="bibr">18</xref>]. Further studies in FHM KI mice indicate that such gain-of-channel-function specifically enhances excitatory transmission at cortical synapses to favor initiation and propagation of cortical spreading depression (CSD), an abnormal increase of cortical activity -followed by a long-lasting neuronal suppression wave- that propagates across the cortex and triggers the aura and migraine itself [<xref rid="pone.0146035.ref010" ref-type="bibr">10</xref>&#x2013;<xref rid="pone.0146035.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0146035.ref016" ref-type="bibr">16</xref>&#x2013;<xref rid="pone.0146035.ref020" ref-type="bibr">20</xref>].</p>
      <p>Episodic ataxia type 2 (EA2), is a rare neurological disorder, typically with childhood onset (although late-onset EA2 has been also reported [<xref rid="pone.0146035.ref021" ref-type="bibr">21</xref>]), characterized by paroxysmal attacks (lasting hours to days) of cerebellar dysfunction which are commonly triggered by emotional and physical stress. Some patients may exhibit mild interictal cerebellar ataxia or isolated nystagmus or, more rarely, severe progressive ataxia [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>]. EA2 is caused by <italic>CACNA1A</italic> mutations that mostly result in truncation of the encoded Ca<sub>V</sub>2.1 &#x3B1;<sub>1A</sub> channel subunit, while missense mutations have also been reported [<xref rid="pone.0146035.ref022" ref-type="bibr">22</xref>]. Although most of the missense mutations are located in the pore regions of the channel, there are at least five mutations of highly conserved residues found in the voltage sensor domains [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0146035.ref023" ref-type="bibr">23</xref>&#x2013;<xref rid="pone.0146035.ref025" ref-type="bibr">25</xref>]. Usually, these mutations have negative effects on both channel activity and trafficking to the plasma membrane when studied in heterologous expression systems [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0146035.ref023" ref-type="bibr">23</xref>&#x2013;<xref rid="pone.0146035.ref026" ref-type="bibr">26</xref>]. At present it is unknown whether aberrant trafficking of Ca<sub>V</sub>2.1 EA2 mutants also occurs in patients&#x2019; neurons. It has been reported that the spontaneous ataxic mouse model rolling Nagoya (carrying Ca<sub>V</sub>2.1 R1262G mutation at S4- DIII) has reduced voltage sensitivity and activity of the Ca<sub>V</sub>2.1 channel but shows unaltered expression in mouse cerebellar Purkinje cells in contrast to heterologously expressed R1262G channels showing strongly reduced expression and/or targeting to the plasma membrane [<xref rid="pone.0146035.ref027" ref-type="bibr">27</xref>]. Therefore, other channel function modifications beyond the decreased intracellular trafficking may lie beneath the pathophysiological role of Ca<sub>V</sub>2.1 in EA2 patients. In this sense, it has been reported that several Ca<sub>V</sub>2.1 EA2 mutations (affecting either pore or voltage sensor regions) produce loss-of-channel-function by shifting channel activation to more depolarized voltages [<xref rid="pone.0146035.ref025" ref-type="bibr">25</xref>,<xref rid="pone.0146035.ref026" ref-type="bibr">26</xref>,<xref rid="pone.0146035.ref028" ref-type="bibr">28</xref>&#x2013;<xref rid="pone.0146035.ref031" ref-type="bibr">31</xref>], thus reducing Ca<sub>V</sub>2.1 open probability [<xref rid="pone.0146035.ref031" ref-type="bibr">31</xref>]. Besides, A454T mutation (located at the first intracellular loop connecting domains I and II of &#x3B1;<sub>1A</sub>) has been linked to a heterogeneous ataxic disorder with clinical features midway between EA2 and spinocerebellar ataxia type 6 (SCA6, other allelic disorder associated with mutations in the <italic>CACNA1A</italic> gene) [<xref rid="pone.0146035.ref032" ref-type="bibr">32</xref>]. Mutation A454T also produces loss-of-channel function by altering the functional interaction between &#x3B1;<sub>1A</sub> and SNARE proteins thus leading to a decreased channel coupling to exocytosis [<xref rid="pone.0146035.ref002" ref-type="bibr">2</xref>]. Regardless of the mechanism employed by Ca<sub>V</sub>2.1 EA2 mutations, studies derived from an EA2 KI mouse model (carrying the loss-of-function pore mutation F1406C) suggest that motor deficit apparently results from subtle dysfunction of multiple cerebellar cell types [<xref rid="pone.0146035.ref033" ref-type="bibr">33</xref>].</p>
      <p>SCA6 is a late-onset slowly progressive ataxic syndrome with underlying cerebellar atrophy. It is caused by small expansions of a polyglutamine (polyQ) sequence, encoded by CAG trinucleotide repeats, at the C-terminal end of some Ca<sub>V</sub>2.1 splice variants [<xref rid="pone.0146035.ref034" ref-type="bibr">34</xref>]. Studies in SCA6 KI mice show that the polyQ expansions do not alter Ca<sub>V</sub>2.1 biophysical properties and suggest that the markedly selective degeneration of cerebellar Purkinje cells (and the subsequent motor impairment) is due to the toxic accumulation of the expanded polyQ channel [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0146035.ref035" ref-type="bibr">35</xref>].</p>
      <p>Several HM-linked <italic>CACNA1A</italic> gain-of-function mutations also produce permanent cerebellar symptoms ranging from slowly progressive cerebellar ataxia and/or nystagmus (with cerebellar atrophy in some cases) [<xref rid="pone.0146035.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0146035.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0146035.ref037" ref-type="bibr">37</xref>] or permanent ataxia [<xref rid="pone.0146035.ref038" ref-type="bibr">38</xref>,<xref rid="pone.0146035.ref039" ref-type="bibr">39</xref>] to early-onset cerebellar signs consistent with congenital ataxia [<xref rid="pone.0146035.ref040" ref-type="bibr">40</xref>&#x2013;<xref rid="pone.0146035.ref044" ref-type="bibr">44</xref>]. In an attempt to understand how a <italic>CACNA1A</italic> HM mutation can also lead to such severe clinical phenotype, the deletion of a highly conserved phenylalanine located at the S6 pore region of &#x3B1;<sub>1A</sub> domain III (&#x394;F1502), found in a case of congenital ataxia and hemiplegic migraine, has recently been functionally characterized [<xref rid="pone.0146035.ref044" ref-type="bibr">44</xref>]. The study, performed in <italic>Xenopus</italic> oocytes as heterologous expression system, only revealed discrete alterations in Ca<sub>V</sub>2.1 channel function of unclear pathophysiological relevance, since channel activity was measured with Ba<sup>2+</sup> as the charge carrier and not with the physiological permeant ion Ca<sup>2+</sup>. The most relevant detected effect was an ~ 11 mV hyperpolarizing shift of the voltage-dependent channel activation, similar to the one reported for all HM mutations analyzed so far (including those that do not lead to cerebellar symptoms) [<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0146035.ref014" ref-type="bibr">14</xref>] (for a review see [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>]). Such gain-of-function effect fits well with a pathophysiological role of mutation &#x394;F1502 in HM but it seems not enough to explain its involvement in congenital ataxia <italic>per se</italic> [<xref rid="pone.0146035.ref044" ref-type="bibr">44</xref>]. Here, we analyze the functional consequences of the &#x394;F1502 &#x3B1;<sub>1A</sub> mutation (found in a second case of congenital ataxia) on Ca<sub>V</sub>2.1 human channels heterologously expressed in mammalian tsA-201 HEK cells, using the physiological ion Ca<sup>2+</sup> as the charge carrier. Our results reveal that &#x394;F1502 is a strong gain-of-function mutation, as it powerfully decreases the voltage threshold for channel activation (by ~ 21 mV). This effect, in combination with &#x394;F1502-induced changes in the kinetics of activation, deactivation and inactivation of Ca<sub>V</sub>2.1 channels, allow significantly higher Ca<sup>2+</sup> influx in response to stimuli of physiological traits, and support the causative role of &#x394;F1502 (and, by extension, of other gain-of-function Ca<sub>V</sub>2.1 mutations) in congenital ataxia and/or cerebellar atrophy.</p>
    </sec>
    <sec sec-type="materials|methods" id="sec002">
      <title>Materials and Methods</title>
      <sec id="sec003">
        <title>Brain Magnetic Resonance Imaging (MRI) Protocol</title>
        <p>MR data were acquired using a 1.5 T scanner (MAGNETOM Symphony or MAGNETOM Vision, Siemens, Erlangen, Germany) equipped with a circular polarized receiver head array coil. Sagittal, transverse and coronal conventional spin-echo T1-weighted sequences were obtained (repetition time [TR] /echo time [TE]/acquisitions 450&#x2013;600 ms/12-20 ms/2). In addition, transverse T2-weighted fast spin-echo (TR 4300 ms/TE 96 ms/acquisitions 1&#x2013;2) and fast-FLAIR (TR 8500 ms/ TE 104 ms/ inversion time 2500 ms/acquisitions1) were also performed. All sequences were obtained with 4-5-mm section thickness and .1-.3 interslice gap, 144&#x2013;256 &#xD7; 256&#x2013;384 matrix, and 196 &#xD7; 230 mm field of view.</p>
      </sec>
      <sec id="sec004">
        <title>Genetic Analyses</title>
        <sec id="sec005">
          <title>Sample preparation and sequencing</title>
          <p>DNA from the trio (patient and parents) was extracted from blood following a standard salting-out protocol. An ultra sound device (Covaris, Woburn, MA, USA) was used for shearing of 1&#x3BC;g of genomic DNA aiming for a fragment size of 300-400bp. Library generation was performed using the TruSeq DNA kit (Illumina, San Diego, CA, USA) following supplier&#x2019;s instructions. Pools of six samples were subjected to whole exome capture applying Nimblegene SeqCap EZ Human Exome version 3 (Roche NimbleGen, Madison, WI, USA) followed by sequencing on a HiSeq 2500 using the 2x100bp protocol. We obtained a coverage of at least 30-fold in &gt; 80% of the probes.</p>
        </sec>
        <sec id="sec006">
          <title>Alignment and variant detection</title>
          <p>Sequencing data preparation, read alignment and variant prediction was performed according to the &#x2018;GATK best practice&#x2019; recommendations for a small number of samples [<xref rid="pone.0146035.ref045" ref-type="bibr">45</xref>]. In brief, sequencing reads were aligned to the hg19 reference genome using BWA-MEM (version 0.7.7) [<xref rid="pone.0146035.ref046" ref-type="bibr">46</xref>], followed by GATK indel realignment and base quality recalibration. Variants were predicted using GATK UnifiedGenotyper (version 3.1.1) (SNVs) and ClinDel (Indels) [<xref rid="pone.0146035.ref047" ref-type="bibr">47</xref>] in regions covered by SeqCap probes extended by 150 nt.</p>
        </sec>
        <sec id="sec007">
          <title>Variant annotation and prioritization</title>
          <p>Identified genetic variants were subjected to annotation using ANNOVAR [<xref rid="pone.0146035.ref048" ref-type="bibr">48</xref>]. In addition information on population allele frequencies (1000 genomes, Exome Variant Server, dbSNP), damage estimation (PolyPhen-2 [<xref rid="pone.0146035.ref049" ref-type="bibr">49</xref>], SIFT [<xref rid="pone.0146035.ref050" ref-type="bibr">50</xref>], Condel [<xref rid="pone.0146035.ref051" ref-type="bibr">51</xref>], CADD [<xref rid="pone.0146035.ref052" ref-type="bibr">52</xref>]), evolutionary conservation in mammals (phastCons [<xref rid="pone.0146035.ref053" ref-type="bibr">53</xref>]) and genomic structure (e.g. segmental duplications) was supplemented using an in-house database.</p>
          <p>To identify potentially causal variants, annotated variants were subjected to filtering and prioritization using both functional annotations (e.g. population allele frequency, impact on protein function, conservation etc.) and pedigree information. We performed causal variant prioritization based on four possible modes of inheritance: recessive, compound heterozygous, X-linked and <italic>de novo</italic>. The reduced gene list was furthermore ranked using ENDEAVOUR [<xref rid="pone.0146035.ref054" ref-type="bibr">54</xref>], which has been trained on a list of known genes related to spinocerebellar ataxias (SCA) extracted from Online Mendelian Inheritance in Man (OMIM) [<xref rid="pone.0146035.ref055" ref-type="bibr">55</xref>] and the muscle gene table [<xref rid="pone.0146035.ref056" ref-type="bibr">56</xref>]. The list of training genes consisted of <italic>ABCB7</italic>, <italic>AFG3L2</italic>, <italic>ANO10</italic>, <italic>ATP2B3</italic>, <italic>ATXN1</italic>, <italic>ATXN2</italic>, <italic>ATXN3</italic>, <italic>ATXN7</italic>, <italic>ATXN8</italic>, <italic>ATXN10</italic>, <italic>ATXN8OS</italic>, <italic>BEAN1</italic>, <italic>C10orf2</italic>, <italic>CABC1</italic>, <italic>CACNA1A</italic>, <italic>EEF2</italic>, <italic>FGF14</italic>, <italic>GRM1</italic>, <italic>ITPR1</italic>, <italic>KCNC3</italic>, <italic>KCND3</italic>, <italic>NOP56</italic>, <italic>PDYN</italic>, <italic>PNPLA6</italic>, <italic>POLG</italic>, <italic>PPP2R2B</italic>, <italic>PRKCG</italic>, <italic>SETX</italic>, <italic>SPTBN2</italic>, <italic>SYNE1</italic>, <italic>SYT14</italic>, <italic>TBP</italic>, <italic>TDP1</italic>, <italic>TGM6</italic>, <italic>TPP1</italic>, <italic>TTBK2</italic>, <italic>WWOX</italic>, <italic>ZNF592</italic>. The highest ranking variant in the affected child (<italic>de novo</italic> indel in <italic>CACNA1A</italic>) was selected for further validation and functional studies.</p>
        </sec>
        <sec id="sec008">
          <title>Sanger Validation</title>
          <p>Direct sequencing was carried out to confirm the <italic>CACNA1A de novo</italic> indel identified through whole-exome sequencing (WES). To that end, <italic>CACNA1A</italic> exon 28 (containing the nucleotide triplet deleted) from the proband and progenitors, was amplified by PCR, purified and sequenced using the BigDye Terminator cycle sequencing kit v3.1 and an automated sequencer ABI PRISM 3730 DNA Analyzer (Applied Biosystems, Foster City, CA, USA) (primer sequences and PCR procedures are available from the authors upon request).</p>
        </sec>
      </sec>
      <sec id="sec009">
        <title>Ethics Statement</title>
        <p>The present investigation was conducted according to the principles expressed in the Declaration of Helsinki and was approved by the Ethics Committee of the Institute for Research in Biomedicine (IRB) at Vall d&#x2019;Hebron University Hospital. Written informed consent was obtained from the parents for participation in this study, including the genetic analyses in the trio (patient and his parents) and the pathological analyses in the patient.</p>
      </sec>
      <sec id="sec010">
        <title>cDNA Constructs and Site-Directed Mutagenesis</title>
        <p>cDNA of the human voltage-gated Ca<sup>2+</sup> (Ca<sub>V</sub>2.1) channel &#x3B1;<sub>1A</sub> subunit (originally cloned into a pCMV vector) was a gift from Professor J. Striessnig (University of Innsbruck, Austria). cDNAs of the rabbit &#x3B1;<sub>2</sub>&#x3B4; and rat &#x3B2;<sub>3</sub> regulatory subunits (subcloned into a pcDNA3 expression vector) were gifts from Dr. L. Birnbaumer (National Institutes of Health, North Carolina, USA). Ca<sub>V</sub>2.1 &#x394;F1502 mutant channel was generated by deleting the CTT codon corresponding to residue F1502 of the human &#x3B1;<sub>1A</sub> subunit using site-directed mutagenesis (GenScript Corporation, Piscatway, NJ).</p>
        <p>All cDNA clones used in this study were sequenced in full to confirm their integrity.</p>
      </sec>
      <sec id="sec011">
        <title>Heterologous Expression and Electrophysiology</title>
        <p>tsA-201 HEK cells were transfected using a linear polyethylenimine (PEI) derivative, the polycation ExGen500 (Fermentas Inc., Hanover, Maryland, USA) as previously reported (eight equivalents PEI/3.3 &#x3BC;g DNA/dish) [<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>]. Transfection was performed using the ratio for &#x3B1;<sub>1A</sub> (wild-type (WT) or &#x394;F1502), &#x3B2;<sub>3</sub>, &#x3B1;<sub>2</sub>&#x3B4;, and EGFP (transfection marker) cDNA constructs of 1:1:1:0.3. Recordings were done 24&#x2013;48 h after transfection at room temperature (22&#x2013;24&#xB0;C).</p>
        <p>Ca<sup>2+</sup> currents (I<sub>Ca</sub><sup>2+</sup>) through WT or &#x394;F1502 Ca<sub>V</sub>2.1 channels were measured using the whole-cell configuration of the patch-clamp technique as described in detail previously [<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>]. In brief, pipettes had a resistance of 2&#x2013;3 M&#x3A9; when filled with a solution containing (in mM): 140 CsCl, 1 EGTA, 4 Na<sub>2</sub>ATP, 0.1 Na<sub>3</sub>GTP, and 10 HEPES (pH 7.2&#x2013;7.3 and 290&#x2013;300 mOsmol/l). The external solution contained (in mM): 140 tetraethylammonium-Cl (TEACl), 3 CsCl, 2.5 CaCl<sub>2</sub>, 1.2 MgCl<sub>2</sub>, 10 HEPES and 10 D-glucose (pH 7.4 and 300&#x2013;310 mOsmol/l). When measuring Ba<sup>2+</sup> currents, CaCl<sub>2</sub> was replaced with an equimolar concentration of BaCl<sub>2</sub>. Recordings were obtained with a D-6100 Darmstadt amplifier (List Medical, Germany) and the pClamp8 software (Axon Instruments, Foster City, CA, USA) was used for pulse generation, data acquisition and subsequent analysis.</p>
        <p>Peak inward Ca<sup>2+</sup> currents in response to 20 ms depolarizing pulses were measured from cells clamped at -80 mV, as described in detail previously [<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>]. In order to obtain the voltage-dependence of channel activation, single normalized current-voltage (I-V) relationships were fitted with the modified Boltzmann equation, as previously reported [<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>]:
<disp-formula id="pone.0146035.e001"><alternatives><graphic xlink:href="pone.0146035.e001.jpg" id="pone.0146035.e001g" position="anchor" mimetype="image" orientation="portrait"/><mml:math id="M1"><mml:mi>I</mml:mi><mml:mi mathvariant="normal">&#xA0;</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">&#xA0;</mml:mi><mml:mfrac><mml:mrow><mml:mi>G</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:mi>V</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>v</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mo>-</mml:mo><mml:mo>(</mml:mo><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:mi>V</mml:mi><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn><mml:mi mathvariant="normal">&#xA0;</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math></alternatives><label>(1)</label></disp-formula>
where I is the peak current, G<sub>max</sub> is the maximal conductance of the cell, V is the membrane potential, V<sub>rev</sub> is the extrapolated reversal potential of I<sub>Ca</sub><sup>2+</sup>, V<sub>1/2 act</sub> is the voltage for half-maximal current activation, and k<sub>act</sub> is the slope factor of the Boltzmann term.</p>
        <p>Kinetics of activation, deactivation, inactivation and recovery from inactivation for WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels were estimated as described in detail previously [<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>], with slight modifications. In particular, time constants for deactivation (&#x3C4;<sub>deactivation</sub>) were obtained from single exponential fits of tail currents obtained with 10 ms prepulse to +20 mV (for WT channels) or -5 mV (for &#x394;F1502 channels) (to maximally open Ca<sub>V</sub>2.1 channels) and followed by test pulses between -80 and 0 mV (in 5 mV steps) for 30 ms; and time course of I<sub>Ca</sub><sup>2+</sup> recovery from inactivation was tested by applying a second pulse of 50 ms to +20 mV at increasing time intervals (1&#x2013;206 s) after an inactivating 3 s prepulse, and relative current at different times (normalized by the peak Ca<sup>2+</sup> current obtained during the 3s prepulse) was fitted to a single exponential.</p>
        <p>The voltage dependence of steady-state inactivation was estimated by measuring peak Ca<sup>2+</sup> currents in response to depolarizing pulses (to +20 mV for WT channels and to -5 mV for &#x394;F1502 channels) from a holding of -80 mV, following 30 s steps to various holding potentials (conditioning pulses) between -80 and +5 mV. As described in detail previously [<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>], half-maximal voltage (V<sub>1/2 inact</sub>) and slope factor (k<sub>inact</sub>) for steady-state inactivation were obtained by fitting normalized I<sub>Ca</sub><sup>2+</sup> persistent currents to the following Boltzmann equation:
<disp-formula id="pone.0146035.e002"><alternatives><graphic xlink:href="pone.0146035.e002.jpg" id="pone.0146035.e002g" position="anchor" mimetype="image" orientation="portrait"/><mml:math id="M2"><mml:mfrac><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:mfrac><mml:mi mathvariant="normal">&#xA0;</mml:mi><mml:mo>=</mml:mo><mml:mi mathvariant="normal">&#xA0;</mml:mi><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>V</mml:mi><mml:mo>-</mml:mo><mml:mi>V</mml:mi><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn><mml:mi mathvariant="normal">&#xA0;</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mi>k</mml:mi><mml:mi>i</mml:mi><mml:mi>n</mml:mi><mml:mi>a</mml:mi><mml:mi>c</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mrow></mml:msup></mml:mrow></mml:mfrac></mml:math></alternatives><label>(2)</label></disp-formula></p>
        <p>The quality of all fittings performed in the present work was always high, with adjusted R-squared values close to 1 (ranging between 0.95 and 0.99).</p>
        <p>Ca<sup>2+</sup> entry through WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels was also measured in response to three different action potential-like waveforms (APWs) that have been reported to represent a wide range of action potential durations present in neurons [<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0146035.ref057" ref-type="bibr">57</xref>]. In brief, the duration above half-amplitude and the rising phase slope were, respectively: 0.5 ms and 367 mV/ms for the fast APW, 1 ms and 114 mV/ms for the medium APW and 2.2 ms and 105 mV/ms for the slow APW. All APWs were normalized to a resting potential of -80 mV and peak amplitude of +30 mV). Ca<sup>2+</sup> currents were acquired at 33 kHz and corrected for leak and capacitive currents using the leak subtraction procedure (P/4). As described previously [<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>], total Ca<sup>2+</sup> influx (Q<sub>Ca</sub><sup>2+</sup>) in response to APWs was calculated as the integral of the Ca<sup>2+</sup> current delimited by the time point at which inward current initially diverged from the baseline, and the time at which it returned to baseline. That time was considered as the time for Ca<sup>2+</sup> entry. Trains of 1000 fast and medium APWs (applied at the highest frequency allowed by the corresponding electrophysiological protocol including P/4 leak subtraction procedure: 50 Hz and 42 Hz, respectively) were applied in some experiments in order to measure Ca<sup>2+</sup> entry through WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels in response to repetitive, brief depolarization of physiological relevance in neurons. Accumulative Ca<sup>2+</sup> influx along the different trains of APWs was calculated by adding the Q<sub>Ca</sub><sup>2+</sup> values obtained for each single APW stimulus in the corresponding train.</p>
      </sec>
      <sec id="sec012">
        <title>Statistics</title>
        <p>Data are presented as the means &#xB1; S.E.M. Statistical tests included unpaired or paired Student&#x2019;s <italic>t</italic> test or, Mann-Whitney U-test, as appropriate. Differences were considered significant if P &lt; 0.05.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="sec013">
      <title>Results</title>
      <sec id="sec014">
        <title>&#x394;F1502 Ca<sub>V</sub>2.1 Mutant in a Spanish Case of Congenital Ataxia</title>
        <p>This 7 year-old boy was normally born after an uneventful pregnancy to unrelated parents. He was noted to be hypotonic and lag behind in motor development over the first months of life. A younger 3 year-old brother is healthy. Examination at the age of 5 months, revealed an alert, non-dysmorphic infant, with good visual fixation but saccadization of pursuit gaze; there was global hypotonia without any evidence of muscle weakness or atrophy; deep tendon reflexes were preserved. Motor development was delayed from early on: he attained head control by age 6 months, sat unassisted at age 3 years. Currently remains in the upright position with aid of a stander and uses a wheel chair for ambulation.</p>
        <p>At the age of 7 years the patient has developed a complete ataxic syndrome. He is able to understand simple commands and speaks in short sentences. He is quite sociable and attends a special school. He is able to draw or self-feed with spoon. On examination, he is normocephalic and there are no telangiectasias or organomegalies. There is a fine, conjugate horizontal/rotary nystagmus and a complex alteration of ocular pursuit that resembles oculomotor apraxia, prominent head and trunk titubation, diffuse hypotonia, normal strength, brisk deep-tendon reflexes, flexor plantar responses and mild upper limb dysmetria with no tremor. He can adopt a quadrupedal position but is not able to stand or walk holding onto furniture. Ancillary tests included serum creatine kinase, vitamin E, alpha fetoprotein, immunoglobulins, thyroid hormones, amino acids, transferrin isoelectric focusing, urine organic acids, CSF lactate, pterins, folate and dopamine and serotonin metabolites. A comparative genomic hybridization array showed a 225 Kb segmental monosomy in the sexual chromosomes pseudoautosomal region (PAR2). Although this rearrangement affected the dose of <italic>SPRY3</italic> and <italic>VAMP7</italic>, it was also found in his asymptomatic father. Fibroblast beta-galactosidase, beta-D-glucuronidase, beta-glucosidase, beta-N-acetyl-glucosaminidase, hexosaminidase A, alpha-galactosidase and alpha-glucosidase activities were normal. A neurophysiological study showed normality of motor and sensory neurography, EMG and somatosensory evoked responses. Visual evoked potentials (flash) and electroretinogram were normal. A muscle biopsy disclosed normal histochemistry and normal activities of the respiratory chain enzymes. A brain magnetic resonance imaging (MRI) at the age of 14 months did not reveal alterations. Subsequent studies performed at the ages of 28 months and 4 years showed a conspicuous and progressive, predominantly vermian, cerebellar atrophy with no involvement of other brain areas (<xref rid="pone.0146035.g001" ref-type="fig">Fig 1</xref>).</p>
        <fig id="pone.0146035.g001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0146035.g001</object-id>
          <label>Fig 1</label>
          <caption>
            <title>Brain MRI of the proband at the age of 14 months (A), 28 months (B), and 4 and a half years (C,D).</title>
            <p>After the initial normal findings (A), note the progressive cerebellar atrophy mainly involving the complete vermis (indicated by the arrows in B, C). The hemispheres, displaying prominence of the cerebellar folia, were eventually affected (D).</p>
          </caption>
          <graphic xlink:href="pone.0146035.g001"/>
        </fig>
        <p>Due to the large number of genes potentially causing cerebellar ataxia, we performed whole exome sequencing (WES) of a parent-child trio with an unknown cause of congenital ataxia in the child. Variant detection on the sequencing data using GATK [<xref rid="pone.0146035.ref045" ref-type="bibr">45</xref>] and ClinDel [<xref rid="pone.0146035.ref047" ref-type="bibr">47</xref>] yielded 115,818 and 12,753 variants, respectively. Variants affecting the protein sequence (nonsynonymous or splicing) were filtered based on possible inheritance modes, including <italic>de novo</italic>, recessive, compound heterozygous or X-linked. Variants coherent with one of the inheritance modes were further prioritized based on population allele frequency in EVS and 1000GP (i.e. rare variants with &lt; 1% AF), damage potential based on PolyPhen-2, SIFT, Condel and CADD [<xref rid="pone.0146035.ref049" ref-type="bibr">49</xref>&#x2013;<xref rid="pone.0146035.ref052" ref-type="bibr">52</xref>], evolutionary conservation based on phastCons [<xref rid="pone.0146035.ref053" ref-type="bibr">53</xref>] and finally sequence complexity and repetitiveness (e.g. variants in segmental duplications are removed), finally yielding a total of seven <italic>de novo</italic>, eight recessive and 15 compound heterozygous variants that are rare or novel and highly damaging. The affected 30 genes were subsequently subjected to additional prioritization using ENDEAVOUR [<xref rid="pone.0146035.ref054" ref-type="bibr">54</xref>], which has been trained on genes extracted from various disease gene resources [<xref rid="pone.0146035.ref055" ref-type="bibr">55</xref>,<xref rid="pone.0146035.ref056" ref-type="bibr">56</xref>]. The ENDEAVOUR prioritization highlighted a <italic>de novo</italic> triplet deletion in <italic>CACNA1A</italic> (NM_001127221.1-transcript variant 3:c.4503-4505delCTT) as most likely candidate, as being part of the list of training genes. Furthermore, no other genes after filtering could be linked to the investigated phenotype. Manual review of the respective alignment data supports the presence of the deletion that was confirmed as a <italic>de novo</italic> variant by Sanger sequencing (<xref rid="pone.0146035.g002" ref-type="fig">Fig 2</xref>). This heterozygous <italic>CACNA1A</italic> deletion brings about a &#x394;F1502 change in the Ca<sub>V</sub>2.1 &#x3B1;<sub>1A</sub> channel subunit, previously described in association with both congenital ataxia and hemiplegic migraine [<xref rid="pone.0146035.ref044" ref-type="bibr">44</xref>].</p>
        <fig id="pone.0146035.g002" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0146035.g002</object-id>
          <label>Fig 2</label>
          <caption>
            <title><italic>De novo</italic> heterozygous <italic>CACNA1A</italic> deletion in congenital ataxia with cerebellar atrophy.</title>
            <p>(A) Pedigree of the affected individual carrying the <italic>de novo</italic> heterozygous &#x394;F1502 mutation. White symbols denote healthy individuals and grey, congenital ataxia. (B) Electropherograms showing the deleted nucleotides (bracket) (NM_001127221.1-transcript variant 3:c.4503-4505delCTT) leading to a F1052 deletion (NP_001120693.1). Note the double wild-type (WT) and mutant (&#x394;F1502) sequence in the patient&#x2019;s electropherogram (heterozygous mutation carrier).</p>
          </caption>
          <graphic xlink:href="pone.0146035.g002"/>
        </fig>
      </sec>
      <sec id="sec015">
        <title>&#x394;F1502 Alters Current Density and Activation, Deactivation and Inactivation Features of Human Ca<sub>V</sub>2.1 Channels</title>
        <p>The F1502 residue of the human Ca<sub>V</sub>2.1 &#x3B1;<sub>1A</sub> channel subunit is the third amino acid containing a non-polar aromatic side chain of the three phenylalanine&#x2019;s group (F1500, F1501, F1502), highly conserved in the pore-forming region of the channel. Thus, F1502 residue lies in all S6 segments of domains III (DIII-S6) of all members of the human Ca<sub>V</sub>2 channel family (Ca<sub>V</sub>2.1 or P/Q-type, Ca<sub>V</sub>2.2 or N-type and Ca<sub>V</sub>2.3 or R-type channels). Besides, F1502 is also conserved through evolution as shown by a comparison of orthologous Ca<sub>V</sub>2.1 channels (<xref rid="pone.0146035.g003" ref-type="fig">Fig 3A</xref>). In human Ca<sub>V</sub>1.x and bacterial voltage-gated Na<sup>+</sup> (Na<sub>V</sub>Ab) channels, a different non-polar but aliphatic side chain amino acid (methionine) occupy the equivalent F1502 residue position (<xref rid="pone.0146035.g003" ref-type="fig">Fig 3B</xref>). Ca<sub>V</sub>2.1 F1502 is located eight residues upstream of a highly conserved isoleucine contributing to the ring of hydrophobic residues that seems to form the internal pore gate of voltage-gated ion channels [<xref rid="pone.0146035.ref058" ref-type="bibr">58</xref>]. F1502 homologous methionine residue in the Na<sub>V</sub>Ab crystal structure is facing to the channel pore, without any evident interaction with other segments either in the pore or the voltage-sensing regions (<xref rid="pone.0146035.g003" ref-type="fig">Fig 3B, 3C and 3D</xref>).</p>
        <fig id="pone.0146035.g003" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0146035.g003</object-id>
          <label>Fig 3</label>
          <caption>
            <title>Evolutionary conservation of the F1502 residue and predicted location at the channel pore.</title>
            <p>(A) Sequence alignment of individual S6 segments at domains I to IV (DI-DIV) of human Ca<sub>V</sub>2.x channel &#x3B1;<sub>1</sub> subunits (P/Q type Ca<sub>V</sub>2.1; N-type Ca<sub>V</sub>2.2; R-type Ca<sub>V</sub>2.3), human Ca<sub>V</sub>1.x (L-type) channel &#x3B1;<sub>1</sub> subunits, and the bacterial sodium channel Na<sub>V</sub>Ab (top); sequence alignment of S6-DIII of Ca<sub>V</sub>2.1 channels from different species (as indicated). The three Phenylalanine&#x2019;s group (in red) is conserved in the human Ca<sub>V</sub>2.1 channel &#x3B1;<sub>1A</sub> subunit, where F1502 is located at the third position. This particular amino acid residue is only conserved in S6-DIII of Ca<sub>V</sub>2 type channels. The phenylalanine&#x2019;s group is totally conserved in S6-DIII of Ca<sub>V</sub>2.1 channels from different species. The alignments were performed with T-Coffee (T-Coffee). (B,C,D) Location of the F1502 homologous methionine residue (M209), using the Na<sub>V</sub>Ab structure as a model (PDB 4EKW). A methionine residue is also present at the F1502 position in L-type channels. The side view (B) show a red highlighted M209 residue in Na<sub>V</sub>Ab, which lines the inner pore vestibule of the channel. A view from the cytoplasm looking up through the channel pore show the arrangement of M209 residue in the four Na<sub>V</sub>Ab subunits (C), and a zoom of the pore region from the same view is shown in (D). Images were generated using UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311) [<xref rid="pone.0146035.ref079" ref-type="bibr">79</xref>].</p>
          </caption>
          <graphic xlink:href="pone.0146035.g003"/>
        </fig>
        <p>Maximal Ca<sup>2+</sup> current densities for expressed mutant &#x394;F1502 &#x3B1;<sub>1A</sub> in tsA-201 HEK cells were ~ 60% smaller than current densities for wild-type (WT) &#x3B1;<sub>1A</sub> channels (<xref rid="pone.0146035.g004" ref-type="fig">Fig 4A and 4C</xref>, left panel). The potential for half-maximal activation (V<sub>1/2 act</sub>) was strongly left-shifted for &#x394;F1502 Ca<sub>V</sub>2.1 channels by ~ 21 mV (P &lt; 0.0001, Student&#x2019;s <italic>t</italic> test), with a significant 0.9 mV increase (P &lt; 0.001, Student&#x2019;s <italic>t</italic> test) in the steepness of the activation curve (k<sub>act</sub>) (<xref rid="pone.0146035.g004" ref-type="fig">Fig 4C</xref>, right panel; mean &#xB1; SEM values for V<sub>1/2 act</sub> and k<sub>act</sub> are provided in the figure legend). Accordingly, the maximal Ca<sup>2+</sup> current amplitude was induced by depolarizing pulses to +15 mV or -5 mV for WT or &#x394;F1502 channels, respectively (<xref rid="pone.0146035.g004" ref-type="fig">Fig 4C</xref>). Due to this &#x394;F1502-induced left-shift in Ca<sub>V</sub>2.1 channel activation, Ca<sup>2+</sup> current densities through mutant channels were significantly higher than current densities through WT channels (P &lt; 0.05&#x2013;0.0001, Mann-Whitney U-test) in a range of depolarized voltages with physiological relevance in neurons (from -40 to -5 mV) (<xref rid="pone.0146035.g004" ref-type="fig">Fig 4C</xref>, left panel; <xref rid="pone.0146035.s006" ref-type="supplementary-material">S1 Table</xref>). Activation and deactivation kinetics were also considerably left-shifted in the &#x394;F1502 channel (<xref rid="pone.0146035.g004" ref-type="fig">Fig 4D and 4E</xref>, respectively): the highest <italic>&#x3C4;</italic><sub>activation</sub> for WT (2.5 &#xB1; 0.2 ms, n = 27) or &#x394;F1502 (3.4 &#xB1; 0.3 ms, n = 19) Ca<sup>2+</sup> currents were observed at +5 mV and -20 mV, respectively. In addition, activation kinetics of &#x394;F1502 channels were significantly accelerated (P &lt; 0.05&#x2013;0.0001, Mann-Whitney U-test) in a wide range of depolarizing voltages (from 0 to +55 mV), when compared to WT channels (<xref rid="pone.0146035.g004" ref-type="fig">Fig 4A and 4D</xref>; <xref rid="pone.0146035.s007" ref-type="supplementary-material">S2 Table</xref>). Concerning gate closing, &#x394;F1502 Ca<sub>V</sub>2.1 channels presented slower <italic>&#x3C4;</italic><sub>deactivation</sub> at voltages from -80 to -20 mV (<xref rid="pone.0146035.g004" ref-type="fig">Fig 4B and 4E</xref>; <xref rid="pone.0146035.s008" ref-type="supplementary-material">S3 Table</xref>, P &lt; 0.0001, Mann-Whitney U-test).</p>
        <fig id="pone.0146035.g004" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0146035.g004</object-id>
          <label>Fig 4</label>
          <caption>
            <title>&#x394;F1502 induces a gain-of-function in the heterologously expressed Ca<sub>V</sub>2.1 channel by affecting its activation and deactivation properties.</title>
            <p>(A) Representative current traces elicited by 20 ms depolarizing pulses from -80 mV to the indicated voltages (inset), illustrating the difference in voltage-dependence and activation kinetics between wild-type (WT) (left) and &#x394;F1502 (right) Ca<sub>V</sub>2.1 channels. Dotted lines indicate the zero current level. (B) Representative current traces showing distinct deactivation kinetics of WT (left) and &#x394;F1502 (right) Ca<sub>V</sub>2.1 channels, obtained by hyperpolarizing the cells during 30 ms at the indicated voltages (inset) following a 20 ms depolarizing pulse to +20 mV (for WT channels) or -5 mV (for &#x394;F1502 channels). The zero current level is indicated by dotted lines. (C) Average current density-voltage relationships (left) and normalized I-V curves (right) for WT (open circles, n = 27) and &#x394;F1502 (filled circles, n = 19) Ca<sub>V</sub>2.1 channels expressed in tsA-201 HEK cells. Red box indicates the voltage range at which peak Ca<sup>2+</sup> current densities through &#x394;F1502 channels exceed those produced by WT channels. Average V<sub>1/2 act</sub>, k<sub>act</sub> and V<sub>rev</sub> values were (in mV): WT (open circles, n = 27) 3.8 &#xB1; 0.6, 3.5 &#xB1; 0.15 and 62.4 &#xB1; 1.4; &#x394;F1502 (filled circles, n = 19) -17.1 &#xB1; 0.9, 4.4 &#xB1; 0.19 and 51.6 &#xB1; 2.2, respectively. Average activation (D) and deactivation (E) kinetics of WT (open circles) and &#x394;F1502 Ca<sub>V</sub>2.1 Ca<sup>2+</sup> currents (filled circles) at the indicated voltages.</p>
          </caption>
          <graphic xlink:href="pone.0146035.g004"/>
        </fig>
        <p>Next, we studied whether &#x394;F1502 affects the time course of channel inactivation by analyzing the Ca<sup>2+</sup> current decay during a 3-s test pulse elicited from a holding potential of -80 mV to +20 mV (<xref rid="pone.0146035.g005" ref-type="fig">Fig 5A</xref>). We found that inactivation kinetic for &#x394;F1502 Ca<sub>V</sub>2.1 Ca<sup>2+</sup> currents was significantly slower (&#x3C4;<sub>inactivation</sub> = 397.3 &#xB1; 37.1 ms, n = 8) than for WT currents (&#x3C4;<sub>inactivation</sub> = 121.3 &#xB1; 17.4 ms, n = 10) (<xref rid="pone.0146035.g005" ref-type="fig">Fig 5B</xref>, P &lt; 0.0001, Student&#x2019;s <italic>t</italic> test). However, the rate of recovery from inactivation was unaffected in &#x394;F1502 channels (<xref rid="pone.0146035.g005" ref-type="fig">Fig 5C</xref>, P = 0.5, Student&#x2019;s <italic>t</italic> test). The half-maximal voltage for steady-state inactivation (V<sub>1/2 inact</sub>) induced by 30s conditioning prepulses between -80 and +5 mV was greatly left-shifted (~ 28.5 mV) in &#x394;F1502 channels (P &lt; 0.0001, Student&#x2019;s <italic>t</italic> test), without significant change in the steepness of the inactivation curve (symbolized by k<sub>inact</sub>) (P = 0.89, Mann-Whitney test) (<xref rid="pone.0146035.g005" ref-type="fig">Fig 5D and 5E</xref>).</p>
        <fig id="pone.0146035.g005" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0146035.g005</object-id>
          <label>Fig 5</label>
          <caption>
            <title>&#x394;F1502 affects Ca<sub>V</sub>2.1 channel inactivation properties.</title>
            <p>(A) Representative current traces illustrating the slower inactivation kinetics for &#x394;F1502 Ca<sub>V</sub>2.1 channels (red trace) when compared to WT channels (blue trace), in response to a 3 s depolarizing pulse to +20 mV. (B) Average &#x3C4;<sub>inactivation</sub> values of Ca<sup>2+</sup> currents through WT (open bar, n = 10) and &#x394;F1502 (filled bar, n = 8) Ca<sub>V</sub>2.1 channels, elicited as indicated in panel (A). (C) Similar time course of Ca<sup>2+</sup> current recovery from inactivation for WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels. Average &#x3C4; of current recovery from inactivation obtained after fitting the data to a single exponential (solid color lines), were (in s): WT (open circles, n = 7) 15.5 &#xB1; 1.1; &#x394;F1502 (filled circles, n = 5) 16.9 &#xB1; 2.1 (P = 0.5, Student&#x2019;s <italic>t</italic> test). (D, E) Steady-state inactivation of WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels. Amplitudes of currents elicited by test pulses to +20 mV (for WT channels) or -5 mV (for &#x394;F1502 channels) were normalized to the current obtained after a 30 s prepulse to -80 mV and fitted by a single Boltzmann function (solid color traces) (see <xref rid="sec002" ref-type="sec">Materials and Methods</xref>, <xref rid="pone.0146035.e002" ref-type="disp-formula">Eq 2</xref>). Average V<sub>1/2 inact</sub> and k<sub>inact</sub> values were (in mV): WT (open circles, n = 19) -32.2 &#xB1; 2.1 and -5.3 &#xB1; 0.3; &#x394;F1502 (filled circles, n = 12) -60.7 &#xB1; 1 and -5.2 &#xB1; 0.8, respectively. No significant difference was found for k<sub>inact</sub> values (P = 0.89, Mann-Whitney test).</p>
          </caption>
          <graphic xlink:href="pone.0146035.g005"/>
        </fig>
      </sec>
      <sec id="sec016">
        <title>Effect of &#x394;F1502 over Ca<sub>V</sub>2.1 Mediated Ca<sup>2+</sup> Influx Evoked Either by Single or Trains of Action Potential-Like Waveforms</title>
        <p>To better understand the physiological impact of &#x394;F1502 effects on Ca<sub>V</sub>2.1 channel activity, we measured the Ca<sup>2+</sup> influx through WT and mutant channels elicited by single action potential-like waveforms (APWs) of different durations (fast, medium and slow; <xref rid="pone.0146035.g006" ref-type="fig">Fig 6A</xref>, top; for further details see <xref rid="sec002" ref-type="sec">Materials and Methods</xref> [<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0146035.ref057" ref-type="bibr">57</xref>]). In spite of the significant reduction in maximal Ca<sup>2+</sup> current density produced by &#x394;F1502 (in this set of experiments maximal Ca<sup>2+</sup> current density through &#x394;F1502 channels in response to a 20 ms depolarizing pulse was ~ 50% smaller when compared to WT current, <xref rid="pone.0146035.s001" ref-type="supplementary-material">S1 Fig</xref>, left panel), no significant changes among cells expressing either WT or &#x394;F1502 channels were observed regarding the peak Ca<sup>2+</sup> current density elicited by the different APWs (<xref rid="pone.0146035.g006" ref-type="fig">Fig 6A and 6B</xref>, top panel). Besides, and more important, total Ca<sup>2+</sup> influx (Q<sub>Ca</sub><sup>2+</sup>) in response to APWs was not reduced by &#x394;F1502. Not only that, but the amount of Ca<sup>2+</sup> that entered into the cell in response to fast and medium APWs was significantly higher for cells expressing the Ca<sub>V</sub>2.1 mutant channel (<xref rid="pone.0146035.g006" ref-type="fig">Fig 6A and 6B</xref>, second panel), most probably due to the ~ 18.7 mV &#x394;F1502-induced left-shit in the activation curve observed in this set of cells (<xref rid="pone.0146035.s001" ref-type="supplementary-material">S1 Fig</xref>, right panel). This, in combination with the effects that &#x394;F1502 exerts on channel activation and deactivation kinetics, may also explain another two facts: the time required to reach the peak current density in response to all APWs was always significantly higher in cells expressing the mutant Ca<sub>V</sub>2.1 channel (<xref rid="pone.0146035.g006" ref-type="fig">Fig 6A and 6B</xref>, third panel); and the time of Ca<sup>2+</sup> entry in response to fast and medium APWs was significantly higher in cells expressing the mutant Ca<sub>V</sub>2.1 channel (<xref rid="pone.0146035.g006" ref-type="fig">Fig 6A and 6B</xref>, bottom panel).</p>
        <fig id="pone.0146035.g006" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0146035.g006</object-id>
          <label>Fig 6</label>
          <caption>
            <title>&#x394;F1502 effects on Ca<sup>2+</sup> influx evoked by single action potential-like waveforms (APWs).</title>
            <p>(A) Average Ca<sup>2+</sup> current traces evoked by APWs of different durations (fast (left panels), medium (central panels) and slow (right panels) (see <xref rid="sec002" ref-type="sec">Materials and Methods</xref> for details) obtained from tsA-201 HEK cells expressing WT (blue traces) or &#x394;F1502 (red traces) Ca<sub>V</sub>2.1 channels. Dotted lines stand for the zero current level. (B) Average data for peak Ca<sup>2+</sup> (I<sub>Ca</sub><sup>2+</sup>) current density (top panel), normalized Ca<sup>2+</sup> influx (Q<sub>Ca</sub><sup>2+</sup>) (second panel), time to peak (third panel), and time for Ca<sup>2+</sup> entry (bottom panel) in response to APWs of different durations obtained from cells expressing WT (blue bars, n = 12&#x2013;14) or &#x394;F1502 (red bars, n = 8) Ca<sub>V</sub>2.1 channels (*P &lt; 0.05, **P &lt; 0.001 and ***P &lt; 0.0001 when compared to WT).</p>
          </caption>
          <graphic xlink:href="pone.0146035.g006"/>
        </fig>
        <p>As &#x394;F1502 strongly promotes Ca<sub>V</sub>2.1 channel steady-state inactivation by voltage in response to prolonged depolarization (<xref rid="pone.0146035.g005" ref-type="fig">Fig 5D and 5E</xref>), we also evaluated if this last action is relevant for Ca<sup>2+</sup> influx through the channel under physiological conditions. <italic>In vivo</italic>, neurons do not experience long depolarization to induce Ca<sub>V</sub>2.1 steady-state inactivation. Instead, this effect on Ca<sub>V</sub>2.1 channel activity is mimicked by the occurrence of more physiological stimuli, such as trains of action potentials causing repetitive, brief depolarization [<xref rid="pone.0146035.ref059" ref-type="bibr">59</xref>]. Therefore, given that total Ca<sup>2+</sup> influx (Q<sub>Ca</sub><sup>2+</sup>) in response to single fast and medium APWs was favored by &#x394;F1502, we studied the effect of the mutation on Q<sub>Ca</sub><sup>2+</sup> elicited by trains of fast and medium APWs applied at relatively high frequency in two new sets of experiments, where it can be observed again the reduction in maximal Ca<sup>2+</sup> current density (by ~ 50%) and the shift of the current activation curve to lower voltages (~ 20 mV) induced by &#x394;F1502 (Figs <xref rid="pone.0146035.g007" ref-type="fig">7A</xref> and <xref rid="pone.0146035.g008" ref-type="fig">8A</xref>). The application of a train of fast APWs (1 ms duration, with maximal depolarization to +30 mV from a holding potential of -80 mV, applied at 50 Hz for 20 seconds) did not cause a significant reduction in Ca<sup>2+</sup> influx through WT Ca<sub>V</sub>2.1 channels (Q<sub>Ca</sub><sup>2+</sup> produced by the first APW applied was 1.94 &#xB1; 0.3 fC/pF (n = 9) and at the end of the train the observed Q<sub>Ca</sub><sup>2+</sup> value was 1.76 &#xB1; 0.3 fC/pF (n = 9), P = 0.23, paired Student&#x2019;s <italic>t</italic> test). However, and according to the effect of &#x394;F1502 on Ca<sub>V</sub>2.1 channel steady-state inactivation, the same train of fast APWs produced a small, but significant, reduction (by ~ 19%) in Ca<sup>2+</sup> influx through &#x394;F1502 Ca<sub>V</sub>2.1 channels (from 5.76 &#xB1; 0.7 fC/pF to 4.69 &#xB1; 0.6 fC/pF (n = 7), P &lt; 0.01, paired Student&#x2019;s <italic>t</italic> test) (<xref rid="pone.0146035.g007" ref-type="fig">Fig 7B and 7C</xref>). Nevertheless, in spite of this Ca<sup>2+</sup> entry reduction along the train produced by &#x394;F1502, Q<sub>Ca</sub><sup>2+</sup> after each APW stimulus was always higher for mutant channels (<xref rid="pone.0146035.g007" ref-type="fig">Fig 7B and 7C</xref>) and, therefore, accumulative Ca<sup>2+</sup> influx through &#x394;F1502 Ca<sub>V</sub>2.1 channels was still significantly higher than through WT channels (4.7 &#xB1; 0.4 pC/pF (n = 7) <italic>versus</italic> 1.9 &#xB1; 0.3 pC/pF (n = 9), P &lt; 0.0001, Student&#x2019;s <italic>t</italic> test). Similar conclusions can be drawn from the analysis of studies using trains of medium APWs (2 ms duration, with maximal depolarization to +30 mV from a holding potential of -80 mV, applied at 42 Hz for 23.81 seconds) (<xref rid="pone.0146035.g008" ref-type="fig">Fig 8</xref>). In this case, the train of APWs produced a significant reduction in Ca<sup>2+</sup> influx through both, WT (from 9.27 &#xB1; 2.14 fC/pF to 6.97 &#xB1; 1.57 fC/pF (n = 10), P &lt; 0.01, paired Student&#x2019;s <italic>t</italic> test) and &#x394;F1502 (from 20.81 &#xB1; 1.9 fC/pF to 9.6 &#xB1; 1.3 fC/pF (n = 11), P &lt; 0.0001, paired Student&#x2019;s <italic>t</italic> test) Ca<sub>V</sub>2.1 channels, which was significantly greater for mutant channels (54.65 &#xB1; 4.4% (n = 10) <italic>versus</italic> 23.69 &#xB1; 2.9% (n = 11), P &lt; 0.0001, Student&#x2019;s <italic>t</italic> test) (<xref rid="pone.0146035.g008" ref-type="fig">Fig 8B and 8C</xref>). Yet, accumulative Ca<sup>2+</sup> influx through &#x394;F1502 Ca<sub>V</sub>2.1 channels all along the train was significantly higher than through WT channels (13.4 &#xB1; 1.4 pC/pF (n = 11) <italic>versus</italic> 7.9 &#xB1; 1.8 pC/pF (n = 10), P &lt; 0.05, Student&#x2019;s <italic>t</italic> test) (<xref rid="pone.0146035.g008" ref-type="fig">Fig 8B and 8C</xref>).</p>
        <fig id="pone.0146035.g007" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0146035.g007</object-id>
          <label>Fig 7</label>
          <caption>
            <title>&#x394;F1502 effects on Ca<sup>2+</sup> influx evoked by a 50 Hz train of 1 ms action potential-like waveforms (APWs).</title>
            <p>(A) Average current density-voltage relationships (left) and normalized I-V curves (right) for WT (open circles, n = 9) and &#x394;F1502 (filled circles, n = 7) Ca<sub>V</sub>2.1 channels expressed in tsA-201 HEK cells, before stimulation with a 50 Hz train of 1 ms APWs. In this series of experiments, maximal Ca<sup>2+</sup> current density through Ca<sub>V</sub>2.1 channels is still significantly reduced by &#x394;F1502 (left panel: from -100.92 &#xB1; 12.5 pA/pF (for WT, n = 9) to -47.18 &#xB1; 6.9 pA/pF (for &#x394;F1502, n = 7), P &lt; 0.01, Student&#x2019;s <italic>t</italic> test) and the significant left-shift induced by &#x394;F1502 on the Ca<sub>V</sub>2.1 voltage-dependent activation is also present (right panel: WT V<sub>1/2 act</sub> = 2.27 &#xB1; 1.3 mV (n = 9) <italic>versus</italic> &#x394;F1502 V<sub>1/2 act</sub> = -17.73 &#xB1; 0.4 mV (n = 7), P &lt; 0.0001, Student&#x2019;s <italic>t</italic> test). (B) Representative Ca<sup>2+</sup> current traces evoked by every 200<sup>th</sup> pulse of a 50 Hz train of fast (1 ms) APWs (see <xref rid="sec002" ref-type="sec">Materials and Methods</xref> for details) obtained from two tsA-201 HEK cells expressing either WT (left) or &#x394;F1502 (right) Ca<sub>V</sub>2.1 channels. Dotted lines stand for the zero current level. The corresponding current density-voltage relationships (left) and normalized I-V curves (right), obtained from these two cells before stimulation with a 50 Hz train of fast APWs, are shown at the bottom (maximal Ca<sup>2+</sup> current density through WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels are -91.7 pA/pF and -56.7 pA/pF, respectively; V<sub>1/2 act</sub> values for WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels are -0.5 mV and -18.97 mV, respectively). (C) Average data for Ca<sup>2+</sup> influx normalized by cell size (Q<sub>Ca</sub><sup>2+</sup>) in response to every 5<sup>th</sup> pulse of a 50 Hz train of fast (1 ms) APWs, obtained from cells expressing WT (blue symbols, n = 9) or &#x394;F1502 (red symbols, n = 7) Ca<sub>V</sub>2.1 channels.</p>
          </caption>
          <graphic xlink:href="pone.0146035.g007"/>
        </fig>
        <fig id="pone.0146035.g008" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0146035.g008</object-id>
          <label>Fig 8</label>
          <caption>
            <title>&#x394;F1502 effects on Ca<sup>2+</sup> influx evoked by a 42 Hz train of 2 ms action potential-like waveforms (APWs).</title>
            <p>(A) Average current density-voltage relationships (left) and normalized I-V curves (right) for WT (open circles, n = 10) and &#x394;F1502 (filled circles, n = 11) Ca<sub>V</sub>2.1 channels expressed in tsA-201 HEK cells, before stimulation with a 42 Hz train of 2 ms APWs. In this series of experiments, maximal Ca<sup>2+</sup> current density through Ca<sub>V</sub>2.1 channels is still significantly reduced by &#x394;F1502 (left panel: from -94.26 &#xB1; 18.9 pA/pF (for WT, n = 10) to -47.76 &#xB1; 5.7 pA/pF (for &#x394;F1502, n = 11), P &lt; 0.05, Student&#x2019;s <italic>t</italic> test) and the significant left-shift induced by &#x394;F1502 on the Ca<sub>V</sub>2.1 voltage-dependent activation is also noticed (right panel: WT V<sub>1/2 act</sub> = 2.32 &#xB1; 1.18 mV (n = 10) <italic>versus</italic> &#x394;F1502 V<sub>1/2 act</sub> = -17.74 &#xB1; 0.35 mV (n = 11), P &lt; 0.0001, Student&#x2019;s <italic>t</italic> test). (B) Representative Ca<sup>2+</sup> current traces evoked by every 200<sup>th</sup> pulse of a 42 Hz train of medium (2 ms) APWs (see <xref rid="sec002" ref-type="sec">Materials and Methods</xref> for details) obtained from two tsA-201 HEK cells expressing either WT (left) or &#x394;F1502 (right) Ca<sub>V</sub>2.1 channels. Dotted lines stand for the zero current level. The corresponding current density-voltage relationships (left) and normalized I-V curves (right), obtained from these two cells before stimulation with a 42 Hz train of 2 ms APWs, are shown at the bottom (maximal Ca<sup>2+</sup> current density through WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels are -115.28 pA/pF and -52.27 pA/pF, respectively; V<sub>1/2 act</sub> values for WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels are 2.52 mV and -17.23 mV, respectively). (C) Average data for Ca<sup>2+</sup> influx normalized by cell size (Q<sub>Ca</sub><sup>2+</sup>) in response to every 5<sup>th</sup> pulse of a 42 Hz train of medium (2 ms) APWs, obtained from cells expressing WT (blue symbols, n = 10) or &#x394;F1502 (red symbols, n = 11) Ca<sub>V</sub>2.1 channels.</p>
          </caption>
          <graphic xlink:href="pone.0146035.g008"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec017">
      <title>Discussion</title>
      <p>Genetic variants in the gene encoding the pore-forming Ca<sub>V</sub>2.1 (P/Q-type) channel &#x3B1;<sub>1A</sub> subunit (<italic>CACNA1A</italic>) result in heterogeneous human neurological disorders of autosomal dominant inheritance, including familial and sporadic hemiplegic migraine (FHM/SHM), episodic ataxia type 2 (EA2), and spinocerebellar ataxia type 6 (SCA6). Although hemiplegic migraine (HM) is linked to <italic>CACNA1A</italic> mutations that enhance Ca<sub>V</sub>2.1 channel activity and EA2, on the contrary, is associated to loss-of-function mutations, symptomatology overlap of HM, EA2 and SCA6 are well recognized at the clinical level (reviewed in [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>]). As yet, it is not clear why some <italic>CACNA1A</italic> mutations cause pure FHM and other FHM with cerebellar signs. Functional studies <italic>in vitro</italic> show different effects on Ca<sub>V</sub>2.1 steady-state inactivation, which can be increased, decreased, or unaltered depending on the mutation [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>]. Besides, although all studied mutations share a consistent gain-of-function effect on Ca<sub>V</sub>2.1 channel activation, there are no noticeable differences among these two groups of FHM mutations, with the exception of mutations D715E, S218L [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0146035.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0146035.ref060" ref-type="bibr">60</xref>&#x2013;<xref rid="pone.0146035.ref062" ref-type="bibr">62</xref>] and now &#x394;F1502 (this report). Hence, pure human FHM mutations such as R192Q and Y1245C (within voltage sensor domains of Ca<sub>V</sub>2.1 &#x3B1;<sub>1A</sub> subunit) or V714A (affecting the pore S6 segment of &#x3B1;<sub>1A</sub> domain II) (<xref rid="pone.0146035.s002" ref-type="supplementary-material">S2 Fig</xref>) shift Ca<sub>V</sub>2.1 channel activation to hyperpolarizing voltages by ~ 9 mV [<xref rid="pone.0146035.ref013" ref-type="bibr">13</xref>,<xref rid="pone.0146035.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0146035.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0146035.ref063" ref-type="bibr">63</xref>]. Likewise, human FHM mutations T501M and R583Q (located at voltage sensor domains, <xref rid="pone.0146035.s002" ref-type="supplementary-material">S2 Fig</xref>), which are linked to progressive cerebellar ataxia (with cerebellar atrophy in the case of R583Q) [<xref rid="pone.0146035.ref014" ref-type="bibr">14</xref>], decrease voltage-threshold for channel activation by ~ 7&#x2013;10 mV [<xref rid="pone.0146035.ref014" ref-type="bibr">14</xref>,<xref rid="pone.0146035.ref060" ref-type="bibr">60</xref>]. The same applies to human FHM mutations T666M, I1811L (within pore domains) and R1350Q (also referred as R1349Q and homologous to the mouse R1252Q allele of the tottering, <italic>Cacna1a</italic><sup><italic>tg</italic></sup>, mutant series; located at the voltage sensor S4 segment of &#x3B1;<sub>1A</sub> domain III) (<xref rid="pone.0146035.s002" ref-type="supplementary-material">S2 Fig</xref>), which are linked to congenital ataxia [<xref rid="pone.0146035.ref038" ref-type="bibr">38</xref>&#x2013;<xref rid="pone.0146035.ref043" ref-type="bibr">43</xref>] and shift Ca<sub>V</sub>2.1 channel activation to lower voltages by ~ 6&#x2013;12 mV [<xref rid="pone.0146035.ref063" ref-type="bibr">63</xref>,<xref rid="pone.0146035.ref064" ref-type="bibr">64</xref>]. However, mutation D715E (located at the pore S6 segment of &#x3B1;<sub>1A</sub> domain II, <xref rid="pone.0146035.s002" ref-type="supplementary-material">S2 Fig</xref>) induces a bigger decrease in the voltage-threshold for Ca<sub>V</sub>2.1 channel activation (by ~ 17 mV) [<xref rid="pone.0146035.ref060" ref-type="bibr">60</xref>]. Likewise, the genetic variant S218L (at the loop between S4 and S5 segments of &#x3B1;<sub>1A</sub> domain I, <xref rid="pone.0146035.s002" ref-type="supplementary-material">S2 Fig</xref>) displays one of the largest gains of function on channel activation when compared with other FHM mutations, promoting Ca<sup>2+</sup> influx even at small depolarization, which are insufficient to open wild-type (WT) channels. Such effect can be further potentiated by the slower inactivation kinetics and increased rate of recovery from inactivation reported for the S218L Ca<sub>V</sub>2.1 channel [<xref rid="pone.0146035.ref018" ref-type="bibr">18</xref>,<xref rid="pone.0146035.ref062" ref-type="bibr">62</xref>]. These distinctive effects of mutations D715E and S218L may be enough to explain the severity of the cerebellar symptoms accompanying FHM in the carrier patients, and in particular the more severe clinical phenotype associated to S218L that, in addition to HM attacks and slowly progressive cerebellar ataxia and atrophy, also includes epileptic seizures, coma or profound stupor, and, sometimes fatal, cerebral edema [<xref rid="pone.0146035.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0146035.ref037" ref-type="bibr">37</xref>,<xref rid="pone.0146035.ref039" ref-type="bibr">39</xref>]. Recently, Garc&#xED;a-Segarra et al. have reported the deletion of the highly conserved phenylalanine 1502 (&#x394;F1502, located at the S6 pore region of &#x3B1;<sub>1A</sub> domain III), in association to a case of HM and congenital ataxia [<xref rid="pone.0146035.ref044" ref-type="bibr">44</xref>]. Their study about the functional consequences of &#x394;F1502 on Ca<sub>V</sub>2.1 channel function in <italic>Xenopus</italic> oocytes using Ba<sup>2+</sup> as the charge carrier (instead of the physiological permeant ion Ca<sup>2+</sup>), revealed: 1) an ~ 11 mV hyperpolarizing shift in Ca<sub>V</sub>2.1 voltage-dependent activation, 2) a 30% decrease in Ba<sup>2+</sup> current density at high depolarizing voltages, 3) a shift in the voltage dependence of steady-state inactivation to hyperpolarizing voltages by ~ 14 mV, and 4) a slightly slower recovery from channel inactivation. Although the gain-of-function effect on channel activation fits well with a pathophysiological role of mutation &#x394;F1502 in HM, the relevance of these discrete alterations in Ca<sub>V</sub>2.1 channel activity in the context of congenital ataxia remained unclear [<xref rid="pone.0146035.ref044" ref-type="bibr">44</xref>].</p>
      <p>Here, we report a second case of congenital ataxia, in a 7 year-old boy, linked to the &#x394;F1502 &#x3B1;<sub>1A</sub> mutation, detected by whole-exome sequencing of a parent-child trio. Contrary to the previous reported case (a 13-year-old girl), our patient did not show HM symptoms, although this might be due to its lower age and, therefore, we cannot rule out the possibility that symptoms of HM appear in the future. Besides, our functional study using the physiological permeant ion Ca<sup>2+</sup> provides robust evidences to consider the &#x394;F1502 &#x3B1;<sub>1A</sub> mutation <italic>per se</italic> responsible of such a severe cerebellar phenotype. Thus, &#x394;F1502 affects several biophysical properties of Ca<sup>2+</sup>-conducting Ca<sub>V</sub>2.1 channels heterologously expressed in mammalian tsA-201 HEK cells: 1) strongly shifts the current activation curve towards hyperpolarized potentials (by ~ 21 mV), allowing significantly higher Ca<sup>2+</sup> current densities in a range of depolarized voltages with physiological relevance in neurons, even though the mutation reduces maximal Ca<sup>2+</sup> current density by 50&#x2013;60%; 2) accelerates activation kinetics and slows deactivation kinetics of Ca<sub>V</sub>2.1 within a wide range of voltage depolarization; 3) slows inactivation kinetic; and 4) shifts voltage-dependent steady-state inactivation to lower voltages (by ~ 28 mV). Despite a favored inactivation by voltage found in the mutant channel, &#x394;F1502 final effect on Ca<sub>V</sub>2.1 results in a huge Ca<sup>2+</sup> influx increase in response to stimuli of physiological relevance in neurons, such as either single or trains of action potential-like waveforms (APWs) of different durations. Studies from the homozygous knock-in (KI) mouse carrying the human FHM Ca<sub>V</sub>2.1 R192Q mutation (which decreases voltage threshold of channel activation by ~ 10 mV) reveal that such gain-of-function mutation results in prolonged action potentials in some types of neurons [<xref rid="pone.0146035.ref065" ref-type="bibr">65</xref>]. Our data clearly show that Ca<sup>2+</sup> influx (Q<sub>Ca</sub><sup>2+</sup>), through both WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels, increases with the duration of the action potential-like waveforms (Figs <xref rid="pone.0146035.g006" ref-type="fig">6</xref>, <xref rid="pone.0146035.g007" ref-type="fig">7C</xref> and <xref rid="pone.0146035.g008" ref-type="fig">8C</xref>; <xref rid="pone.0146035.s003" ref-type="supplementary-material">S3B and S3C Fig</xref>). Therefore, in those neuronal cells where Ca<sub>V</sub>2.1 channels contribute to the shape of action potentials, the &#x394;F1502-induced increase in Ca<sup>2+</sup> entry in response to physiological stimuli would be even greater than the one found in our comparisons, stimulating with single or trains of APWs of similar durations both WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels. Besides, the enhanced Ca<sup>2+</sup> influx might even be further underestimated (see <xref rid="pone.0146035.s003" ref-type="supplementary-material">S3</xref> and <xref rid="pone.0146035.s004" ref-type="supplementary-material">S4</xref> Figs) if the observed reduction on maximal Ca<sup>2+</sup> current density (by 50&#x2013;60%) is due to aberrant trafficking of the mutant &#x394;F1502 Ca<sub>V</sub>2.1 channel to the plasma membrane just occurring after heterologous expression in mammalian cells but not in patients&#x2019; neurons. Supporting this idea, the previous &#x394;F1502 functional study only reported a ~ 30% decrease in Ba<sup>2+</sup> currents through mutant channels expressed in <italic>Xenopus</italic> oocytes [<xref rid="pone.0146035.ref044" ref-type="bibr">44</xref>], whereas we have observed a higher ~ 50&#x2013;60% decrease in either Ca<sup>2+</sup> (Figs <xref rid="pone.0146035.g004" ref-type="fig">4C</xref>, <xref rid="pone.0146035.g007" ref-type="fig">7A</xref> and <xref rid="pone.0146035.g008" ref-type="fig">8A</xref>, <xref rid="pone.0146035.s001" ref-type="supplementary-material">S1 Fig</xref>) or Ba<sup>2+</sup> (<xref rid="pone.0146035.s005" ref-type="supplementary-material">S5 Fig</xref>) currents through Ca<sub>V</sub>2.1 &#x394;F1502 channels expressed in tsA-201 HEK cells. Indeed, a decreased density of functional Ca<sub>V</sub>2.1 channels in the membrane (and a consequent decreased maximal whole-cell Ca<sup>2+</sup> current density) depending on the cell expression system has been found for most FHM mutants compared to WT [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>], making difficult to assess both the consequences of this effect <italic>in vivo</italic> and its real contribution to the associated clinical phenotypes, if any. Still, we cannot rule out the possibility that altered pore gating and/or reduced channel conductance, rather than trafficking problems, are underneath the lower maximal current density through &#x394;F1502 Ca<sub>V</sub>2.1 channels.</p>
      <p>At the structural level, the affected F1502 residue is highly conserved in evolution at the interspecies level as well as among the S6 segments of domains III in the human Ca<sub>V</sub>2 channel family (<xref rid="pone.0146035.g003" ref-type="fig">Fig 3A</xref>), indicating functional and/or structural relevance. Based on the crystal structure of the K<sup>+</sup> channel KcsA, Garc&#xED;a-Segarra et al. proposed that F1502 is located in the distal half of S6 &#x3B1; helix that faces the cytosolic side, lining the inner pore vestibule of the channel [<xref rid="pone.0146035.ref044" ref-type="bibr">44</xref>]. We have used a different crystal structural model, the bacterial voltage-gated sodium channel (Na<sub>V</sub>Ab), which shares 30% higher homology with human Ca<sub>V</sub>2.1 (T-Coffee ~ 70% score) than the KcsA structural model (T-Coffee ~ 40% score), and found a similar predicted position in the inner pore vestibule for the F1502 residue. Accordingly, Ca<sub>V</sub>2.1 F1502 is located eight residues upstream of a highly conserved isoleucine contributing to the ring of hydrophobic residues which has been suggested to form the internal pore gate in the voltage-gated ion channel superfamily [<xref rid="pone.0146035.ref058" ref-type="bibr">58</xref>]. Our results, along with those obtained from the functional characterization of other Ca<sub>V</sub>2.1 mutations linked to FHM (with or without severe cerebellar symptoms) and located at the distal part of &#x3B1;<sub>1A</sub> S6 &#x3B1; helices (i.e. V714A, D715E and I1881L, see <xref rid="pone.0146035.s002" ref-type="supplementary-material">S2 Fig</xref>) [<xref rid="pone.0146035.ref060" ref-type="bibr">60</xref>,<xref rid="pone.0146035.ref063" ref-type="bibr">63</xref>], entail a relevant role of the internal pore mouth in the control of Ca<sub>V</sub>2.1 voltage-dependent gating, affecting both activation and inactivation of the channel. Further studies are required to understand the precise molecular mechanisms by which this pore region influences the operation of voltage sensors in the Ca<sub>V</sub>2.1 channel.</p>
      <p>Purkinje cells (PCs) are the sole output from the cerebellar cortex that controls coordination of movement, maintenance of balance and motor learning after integration of multiple sensory and cortical synaptic inputs. Accordingly, defects in PCs firing is thought to be underneath cerebellar dysfunction and ataxia [<xref rid="pone.0146035.ref011" ref-type="bibr">11</xref>]. In this sense, the link between enhanced Ca<sub>V</sub>2.1-mediated Ca<sup>2+</sup> influx (as described here for the &#x394;F1502 mutant channel) and permanent or congenital ataxia can be inferred from studies of the homozygous KI mouse carrying the human pathogenic FHM CACNA1A S218L mutation (<italic>Cacna1a</italic><sup>S218L/S218L</sup>), which exhibits the main features of the severe clinical syndrome linked to this mutation, including mild permanent cerebellar ataxia [<xref rid="pone.0146035.ref066" ref-type="bibr">66</xref>]. Certainly, it has been shown that the gain-of-function S218L mutation decreases the voltage threshold (by ~ 15 mV) for activation of Ca<sub>V</sub>2.1 channels located in the soma and dendrites of mouse PCs, favoring the generation of somatic action potentials and dendritic Ca<sup>2+</sup> spikes, and leading to irregular activity patterns. Interestingly, the action potential amplitude, half-width, maximum rising slope, maximum repolarizing slope, decay time constant as well as the basic membrane properties in Purkinje neurons from S218L KI mice were similar to WT cells. Altogether, these results suggest that Ca<sub>V</sub>2.1 gain-of-function mutations affect the initiation threshold of action potentials, but they do not substantially modulate the characteristics of action potentials in murine cerebellar Purkinje neurons [<xref rid="pone.0146035.ref006" ref-type="bibr">6</xref>]. Besides, PCs hyperexcitability in S218L KI mice is further favored by increased Ca<sup>2+</sup> influx through mutant S218L Ca<sub>V</sub>2.1 channels located at the axon terminals and the subsequent enhancement of neurotransmitter release from excitatory afferent neurons including cerebellar granule cells and neurons in the inferior olive [<xref rid="pone.0146035.ref006" ref-type="bibr">6</xref>]. Independent of whether or not gain-of-function mutations alter the duration of action potentials and/or the firing properties of these afferent neurons (which is unknown at present), the enhanced release of neurotransmitters from their presynaptic terminals is consistent with our observation that single or trains of APWs promote Ca<sup>2+</sup> entry through gain-of-function mutant Ca<sub>V</sub>2.1 channels. Furthermore, both irregular PCs spiking and ataxic motor performance can be counteracted by activators of hyperpolarizing small-conductance Ca<sup>2+</sup>-activated K<sup>+</sup> channels (SK channels), suggesting that the S218L-induced hyperexcitability of PCs is indeed the cause of the ataxic phenotype in the mouse model [<xref rid="pone.0146035.ref006" ref-type="bibr">6</xref>]. Similar or even larger effects on cerebellar circuitry function may be produced by other Ca<sub>V</sub>2.1 gain-of-function mutations (as &#x394;F1502) in humans. Functional alteration of cerebellum circuits by &#x394;F1502 can explain the fact that our patient presented neurological signs soon after birth and well before neuroimaging was able to disclose the slightest degree of cerebellar atrophy, whose subsequent development may be due to excitotoxic Ca<sup>2+</sup> signaling causing PCs degeneration, as proposed for spinocerebellar ataxias [<xref rid="pone.0146035.ref067" ref-type="bibr">67</xref>].</p>
      <p>Disruption of Ca<sup>2+</sup> homeostasis leading to higher intracellular Ca<sup>2+</sup> levels in cerebellar PCs and in synaptic terminals of granule cells has been related with functional and/or developmental defects in the cerebellum, leading to congenital ataxia forms in humans and similar ataxic phenotypes in animal models. Thus, two human missense mutations (S100P and G162R) in the <italic>CA8</italic> gene, encoding carbonic anhydrase 8 (CA8), are linked to mild-to-severe forms of congenital ataxia [<xref rid="pone.0146035.ref068" ref-type="bibr">68</xref>,<xref rid="pone.0146035.ref069" ref-type="bibr">69</xref>]. CA8 is predominantly present in cerebellar PCs, where it interacts with the inositol 1,4,5-trisphosphate receptor type 1 (IP<sub>3</sub>R1). This interaction impairs IP<sub>3</sub> binding [<xref rid="pone.0146035.ref070" ref-type="bibr">70</xref>,<xref rid="pone.0146035.ref071" ref-type="bibr">71</xref>], therefore modulating the ability of IP<sub>3</sub>R1 to rapidly release Ca<sup>2+</sup> from the endoplasmatic reticulum (ER). Mutation S100P induces proteasome-mediated degradation with a severe reduction of the level of CA8 protein [<xref rid="pone.0146035.ref068" ref-type="bibr">68</xref>], which is expected to promote ER-mediated intracellular Ca<sup>2+</sup> signals that in turn may alter PCs synaptic inputs [<xref rid="pone.0146035.ref072" ref-type="bibr">72</xref>,<xref rid="pone.0146035.ref073" ref-type="bibr">73</xref>]. This mutation probably represents a null mutation similar to the 19 bp deletion in the <italic>Ca8</italic> gene of the waddles mouse (a spontaneous animal model with ataxia), in which the lack of detectable Ca8 protein in the cerebellum results in abnormalities in cerebellar synaptic morphology and function [<xref rid="pone.0146035.ref074" ref-type="bibr">74</xref>,<xref rid="pone.0146035.ref075" ref-type="bibr">75</xref>]. More recently, a pivotal role for CA8 during embryonic development has been revealed by the knockdown of CA8 in zebrafish larvae, which results in increased neuronal cell death in the cerebellum and defects in motor and coordination functions, mimicking the CA8-associated ataxic phenotype found in humans and mice [<xref rid="pone.0146035.ref076" ref-type="bibr">76</xref>]. Although no studies are available regarding the effect of mutation G162R on either the function or expression of CA8, a deleterious effect supporting its pathogenicity has been suggested by bioinformatics analysis [<xref rid="pone.0146035.ref069" ref-type="bibr">69</xref>]. A missense mutation (G1107D) in the isoform 3 of the calmodulin-activated plasma membrane Ca<sup>2+</sup> ATPases (PMCAs) has been also associated to congenital cerebellar ataxia. Functional studies in a heterologous expression system show that mutated pump has reduced ability to extrude Ca<sup>2+</sup> from the cell. As PMCA3 is highly expressed in the cerebellum, particularly in the excitatory presynaptic terminals of granule cells that make synapsis on PCs, the mutation might lead to higher basal levels of Ca<sup>2+</sup> and/or altered local Ca<sup>2+</sup> signaling that affect synaptic efficiency and promote PCs hyperexcitability [<xref rid="pone.0146035.ref077" ref-type="bibr">77</xref>].</p>
      <p>In summary, our results highlight the key role of Ca<sub>V</sub>2.1 channel gain-of-function not only in FHM but also in congenital ataxia, making this channel a strong potential drug target for direct, efficient and tailored disease treatment. Indeed, there are pharmacological evidences suggesting that inhibition of channel activity can provide a new therapeutic approach for the treatment of these neurological disorders. Thus, 2,50-di(tertbutyl)-1,4,-benzohydroquinone (BHQ), a synthetic phenolic compound that inhibits sarcoendoplasmic Ca<sup>2+</sup> ATPases (SERCAs) and with pro-oxidant properties, can also inhibit Ca<sub>V</sub>2.1 voltage-dependent activation to ameliorate gating defects in the channel and subsequently prevent synaptic transmission problems produced by the S218L CACNA1A mutation causing a severe form of FHM with slowly progressive cerebellar ataxia and atrophy in humans [<xref rid="pone.0146035.ref078" ref-type="bibr">78</xref>]. Nevertheless, due to the lack of selectivity on Ca<sub>V</sub>2.1 channels, BHQ itself will not be therapeutically suitable, although modification of its chemical structure may yield small-molecule state-dependent selective inhibitors that could correct the mutation-induced gain-of-function in Ca<sub>V</sub>2.1 activation. Such compounds would greatly improve the chances of developing a personalized medicine approach for <italic>CACNA1A</italic>-linked diseased states of the nervous system. So far, true Ca<sub>V</sub>2.1 selective inhibitors are derived agatoxin family peptides. These peptides are not suitable therapeutic tools: their mode of inhibition can give rise to undesirable side effects and have limited utility for <italic>in vivo</italic> studies.</p>
    </sec>
    <sec sec-type="supplementary-material" id="sec018">
      <title>Supporting Information</title>
      <supplementary-material content-type="local-data" id="pone.0146035.s001">
        <label>S1 Fig</label>
        <caption>
          <title>I-V curves corresponding to seals included in the study of &#x394;F1502 effect on Ca<sup>2+</sup> influx evoked by single action potential-like waveforms.</title>
          <p>Average current density-voltage relationships (left) and normalized I-V curves (right) for WT (open circles, n = 14) and &#x394;F1502 (filled circles, n = 8) Ca<sub>V</sub>2.1 channels expressed in tsA-201 HEK cells. In this series of experiments, maximal Ca<sup>2+</sup> current density through Ca<sub>V</sub>2.1 channels is still significantly reduced by &#x394;F1502 (left panel: from -127 &#xB1; 23.4 pA/pF (for WT, n = 14) to -63.5 &#xB1; 15.3 pA/pF (for &#x394;F1502, n = 8), P &lt; 0.05, Student&#x2019;s <italic>t</italic> test) and the significant left-shift induced by &#x394;F1502 on the Ca<sub>V</sub>2.1 voltage-dependent activation is also observed (right panel: WT V<sub>1/2 act</sub> = 1.47 &#xB1; 0.6 mV (n = 14) <italic>versus</italic> &#x394;F1502 V<sub>1/2 act</sub> = -17.2 &#xB1; 1.2 mV (n = 8), P &lt; 0.0001, Student&#x2019;s <italic>t</italic> test).</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pone.0146035.s001.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0146035.s002">
        <label>S2 Fig</label>
        <caption>
          <title>Ca<sub>V</sub>2.1 missense mutations causing early cerebellar dysfunction compatible with congenital cerebellar ataxia.</title>
          <p>(A) Location of human missense mutations associated to congenital ataxia and linked (purple circles) or not (purple triangles) to Familial Hemiplegic Migraine (FHM) in the secondary structure of the Ca<sub>V</sub>2.1 &#x3B1;<sub>1A</sub> channel subunit. For comparison, the location of some pure FHM-linked mutations (red circles) and FHM mutations including progressive ataxia (with cerebellar atrophy in some cases) (cyan circles) are also shown (for details of the corresponding references see <xref rid="pone.0146035.s009" ref-type="supplementary-material">S1 Text</xref>). The functional consequences of mutations shown in green have been characterized either by heterologous expression of recombinant Ca<sub>V</sub>2.1 channels or by electrophysiological studies of native mutant Ca<sub>V</sub>2.1 channels in neurons from knock-in mice. Note that mutation R1350Q has been also referred as R1349Q and is homologous to the mouse R1252Q allele of the tottering, <italic>Cacna1a</italic><sup><italic>tg</italic></sup>, mutant series. (B) Sequences of S4 segments at domains I to IV (DI-DIV) of our Ca<sub>V</sub>2.1 &#x3B1;<sub>1A</sub> channel subunit clone, showing the affected R0 to R5 charged residues (or a neighboring residue) by mutations depicted in (A) (with a similar color pattern to indicate the clinical phenotype linked to the mutation). Positively charged residues in R0 to R5 positions, involved in the movement of the S4 segment in response to voltage, are delineated with a shaded background (gray). Note that R1349Q has been also referred as R1350Q, and R1664Q is equivalent to R1663Q in our &#x3B1;<sub>1A</sub> clone. (C) Sequences of S6 segments at DI-DIV of our Ca<sub>V</sub>2.1 &#x3B1;<sub>1A</sub> channel subunit clone, showing the affected residues by mutations illustrated in (A) (with a similar color pattern to indicate the clinical phenotype associated to the mutation). Note that S1799L and I1811L correspond to S1801L and I1812L in our &#x3B1;<sub>1A</sub> clone, respectively.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pone.0146035.s002.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0146035.s003">
        <label>S3 Fig</label>
        <caption>
          <title>Example of expected &#x394;F1502 effects on Ca<sup>2+</sup> influx evoked by single action potential-like waveforms (APWs) in the case of unaffected current density.</title>
          <p>(A) Current density-voltage relationships (left) and the corresponding normalized I-V curves (right) for two particular tsA-201 HEK cells expressing either WT (open circles) or &#x394;F1502 (filled circles) Ca<sub>V</sub>2.1 channels (maximal Ca<sup>2+</sup> current density through WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels are -87.2 pA/pF and -80.8 pA/pF, respectively; V<sub>1/2 act</sub> values for WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels are 2.95 mV and -15.17 mV, respectively). (B) Ca<sup>2+</sup> current traces evoked by APWs of different durations (fast (left panels), medium (central panels) and slow (right panels) (see <xref rid="sec002" ref-type="sec">Materials and Methods</xref> for details) obtained from the two tsA-201 HEK cells indicated in panel A (showing similar maximal current densities) expressing either WT (blue traces) or &#x394;F1502 (red traces) Ca<sub>V</sub>2.1 channels. Dotted lines indicate the zero current level. (C) Values for normalized Ca<sup>2+</sup> influx (Q<sub>Ca</sub><sup>2+</sup>) (top panel), time to peak (intermediate panel), and time for Ca<sup>2+</sup> entry (bottom panel) in response to the above-mentioned APWs obtained from these two cells expressing either WT (blue bars) or &#x394;F1502 (red bars) Ca<sub>V</sub>2.1 channels.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pone.0146035.s003.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0146035.s004">
        <label>S4 Fig</label>
        <caption>
          <title>Example of expected &#x394;F1502 effects on Ca<sup>2+</sup> influx evoked by a 42 Hz train of 2 ms action potential-like waveforms (APWs) in the case of unaffected current density.</title>
          <p>(A) Current density-voltage relationships (left) and the corresponding normalized I-V curves (right) for two particular tsA-201 HEK cells expressing either WT (open circles) or &#x394;F1502 (filled circles) Ca<sub>V</sub>2.1 channels (maximal Ca<sup>2+</sup> current density through WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels are -87.8 pA/pF and -79.51 pA/pF, respectively; V<sub>1/2 act</sub> values for WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels are 1.56 mV and -15.87 mV, respectively). (B) Ca<sup>2+</sup> current traces evoked by every 200<sup>th</sup> pulse of a 42 Hz train of medium (2 ms) APWs (see <xref rid="sec002" ref-type="sec">Materials and Methods</xref> for details) obtained from the two tsA-201 HEK cells indicated in panel A (showing similar maximal current densities) expressing either WT (left) or &#x394;F1502 (right) Ca<sub>V</sub>2.1 channels. Dotted lines indicate the zero current level. (C) Values for Ca<sup>2+</sup> influx normalized by cell size (Q<sub>Ca</sub><sup>2+</sup>) in response to every 5<sup>th</sup> pulse of a 42 Hz train of medium (2 ms) APWs, obtained from these two cells expressing either WT (blue symbols) or &#x394;F1502 (red symbols) Ca<sub>V</sub>2.1 channels.</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pone.0146035.s004.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0146035.s005">
        <label>S5 Fig</label>
        <caption>
          <title>Effect of &#x394;F1502 on Ca<sub>V</sub>2.1-mediated Ba<sup>2+</sup> currents: reduction in IBa2+ density and &#x223C;11 mV left-shift in the voltage dependence of activation.</title>
          <p>Average current density-voltage relationships normalized by the absolute maximal value (left) and I-V curves normalized by the peak current obtained in each recording (right), for WT (open circles, n = 14) and &#x394;F1502 (filled circles, n = 9) Ca<sub>V</sub>2.1 channels expressed in tsA-201 HEK cells and using 2.5 mM BaCl<sub>2</sub> instead of CaCl<sub>2</sub> in the extracellular recording solution. &#x394;F1502 induces a ~ 61% significant reduction of maximal Ba<sup>2+</sup> currents through Ca<sub>V</sub>2.1 channels (P &lt; 0.01, Mann-Whitney U-test), as found for maximal Ca<sup>2+</sup> currents (see Figs <xref rid="pone.0146035.g004" ref-type="fig">4C</xref>, <xref rid="pone.0146035.g007" ref-type="fig">7A</xref> and <xref rid="pone.0146035.g008" ref-type="fig">8A</xref>, <xref rid="pone.0146035.s001" ref-type="supplementary-material">S1 Fig</xref>). As previously reported [<xref rid="pone.0146035.ref044" ref-type="bibr">44</xref>], when using Ba<sup>2+</sup> as the charge carrier, &#x394;F1502 only induces a significant ~ 11 mV left-shift on the Ca<sub>V</sub>2.1 voltage-dependent activation (right panel: WT V<sub>1/2 act</sub> = -8.23 &#xB1; 1.02 mV (n = 14) <italic>versus</italic> &#x394;F1502 V<sub>1/2 act</sub> = -18.95 &#xB1; 1.8 mV (n = 9), P &lt; 0.001, Mann-Whitney U-test).</p>
          <p>(TIF)</p>
        </caption>
        <media xlink:href="pone.0146035.s005.tif">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0146035.s006">
        <label>S1 Table</label>
        <caption>
          <title>Average peak inward Ca<sup>2+</sup> current densities (pA/pF) through either WT or &#x394;F1502 Ca<sub>V</sub>2.1 channels, elicited by 20 ms depolarizing pulses from a holding of -80 mV to the indicated voltages.</title>
          <p>Data are presented as the means &#xB1; S.E.M. For statistical comparison we used the Mann-Whitney U-test.</p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0146035.s006.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0146035.s007">
        <label>S2 Table</label>
        <caption>
          <title>Average activation kinetics of WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels at the indicated depolarizing voltages.</title>
          <p>Data are presented as the means &#xB1; S.E.M. The Mann-Whitney U-test was employed for statistical comparison.</p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0146035.s007.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0146035.s008">
        <label>S3 Table</label>
        <caption>
          <title>Average deactivation kinetics of WT and &#x394;F1502 Ca<sub>V</sub>2.1 channels at the indicated voltages.</title>
          <p>Data are presented as the means &#xB1; S.E.M. For statistical comparison we used the Mann-Whitney U-test.</p>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0146035.s008.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0146035.s009">
        <label>S1 Text</label>
        <caption>
          <title>References for <xref rid="pone.0146035.s002" ref-type="supplementary-material">S2 Fig</xref>.</title>
          <p>(DOCX)</p>
        </caption>
        <media xlink:href="pone.0146035.s009.docx">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank the patient and its family for their participation. We are grateful to Dr. J. Striessnig (University of Insbruck, Austria) for the gift of human <italic>CACNA1A</italic> cDNA. We also thank Dr. L. Birnbaumer (National Institutes of Health, North Carolina, USA) for the gift of the cDNAs encoding rabbit &#x3B1;<sub>2</sub>&#x3B4;, and rat &#x3B2;<sub>3</sub> regulatory subunits, and Dr. Hyun Hor (Centre for Genomic Regulation, Barcelona, Spain) for his help and advice in the analyses of the Whole Exome Sequencing data.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pone.0146035.ref001">
        <label>1</label>
        <mixed-citation publication-type="journal"><name><surname>Catterall</surname><given-names>WA</given-names></name>. <article-title>Voltage-gated calcium channels</article-title>. <source>Cold Spring Harb Perspect Biol</source>. <year>2011</year>;<volume>3</volume>: <fpage>a003947</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/cshperspect.a003947">10.1101/cshperspect.a003947</ext-link></comment>
<pub-id pub-id-type="pmid">21746798</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref002">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Serra</surname><given-names>SA</given-names></name>, <name><surname>Cuenca-Le&#xF3;n</surname><given-names>E</given-names></name>, <name><surname>Llobet</surname><given-names>A</given-names></name>, <name><surname>Rubio-Moscardo</surname><given-names>F</given-names></name>, <name><surname>Plata</surname><given-names>C</given-names></name>, <name><surname>Carre&#xF1;o</surname><given-names>O</given-names></name>, <etal>et al</etal>
<article-title>A mutation in the first intracellular loop of CACNA1A prevents P/Q channel modulation by SNARE proteins and lowers exocytosis</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2010</year>;<volume>107</volume>: <fpage>1672</fpage>&#x2013;<lpage>1677</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0908359107">10.1073/pnas.0908359107</ext-link></comment>
<pub-id pub-id-type="pmid">20080591</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref003">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Westenbroek</surname><given-names>RE</given-names></name>, <name><surname>Sakurai</surname><given-names>T</given-names></name>, <name><surname>Elliott</surname><given-names>EM</given-names></name>, <name><surname>Hell</surname><given-names>JW</given-names></name>, <name><surname>Starr</surname><given-names>TV</given-names></name>, <name><surname>Snutch</surname><given-names>TP</given-names></name>, <etal>et al</etal>
<article-title>Immunochemical identification and subcellular distribution of the &#x3B1;<sub>1A</sub> subunits of brain calcium channels</article-title>. <source>J Neurosci</source>. <year>1995</year>;<volume>15</volume>: <fpage>6403</fpage>&#x2013;<lpage>6418</lpage>. <pub-id pub-id-type="pmid">7472404</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref004">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>Pineda</surname><given-names>JC</given-names></name>, <name><surname>Waters</surname><given-names>RS</given-names></name>, <name><surname>Foehring</surname><given-names>RC</given-names></name>. <article-title>Specificity in the interaction of HVA Ca<sup>2+</sup> channel types with Ca<sup>2+</sup>-dependent AHPs and firing behavior in neocortical pyramidal neurons</article-title>. <source>J Neurophysiol</source>. <year>1998</year>;<volume>79</volume>: <fpage>2522</fpage>&#x2013;<lpage>2534</lpage>. <pub-id pub-id-type="pmid">9582225</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref005">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Womack</surname><given-names>MD</given-names></name>, <name><surname>Chevez</surname><given-names>C</given-names></name>, <name><surname>Khodakhah</surname><given-names>K</given-names></name>. <article-title>Calcium activated potassium channels are selectively coupled to P/Q type calcium channels in cerebellar Purkinje neurons</article-title>. <source>J Neurosci</source>. <year>2004</year>;<volume>24</volume>: <fpage>8818</fpage>&#x2013;<lpage>8822</lpage>. <pub-id pub-id-type="pmid">15470147</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref006">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>Gao</surname><given-names>Z</given-names></name>, <name><surname>Todorov</surname><given-names>B</given-names></name>, <name><surname>Barrett</surname><given-names>CF</given-names></name>, <name><surname>van Dorp</surname><given-names>S</given-names></name>, <name><surname>Ferrari</surname><given-names>MD</given-names></name>, <name><surname>van den Maagdenberg</surname><given-names>AMJM</given-names></name>, <etal>et al</etal>
<article-title>Cerebellar ataxia by enhanced Ca<sub>V</sub>2.1 currents is alleviated by Ca<sup>2+</sup>-dependent K<sup>+</sup>-channel activators in <italic>Cacna1a</italic><sup>S218L</sup> mutant mice</article-title>. <source>J Neurosci</source>. <year>2012</year>;<volume>32</volume>: <fpage>15533</fpage>&#x2013;<lpage>15546</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1523/JNEUROSCI.2454-12.2012">10.1523/JNEUROSCI.2454-12.2012</ext-link></comment>
<pub-id pub-id-type="pmid">23115190</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref007">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>Sutton</surname><given-names>KG</given-names></name>, <name><surname>McRory</surname><given-names>JE</given-names></name>, <name><surname>Guthrie</surname><given-names>H</given-names></name>, <name><surname>Murphy</surname><given-names>TH</given-names></name>, <name><surname>Snutch</surname><given-names>TP</given-names></name>. <article-title>P/Q-type calcium channels mediate the activity-dependent feedback of syntaxin-1A</article-title>. <source>Nature</source>. <year>1999</year>;<volume>401</volume>: <fpage>800</fpage>&#x2013;<lpage>804</lpage>. <pub-id pub-id-type="pmid">10548106</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref008">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Eilers</surname><given-names>J</given-names></name>, <name><surname>Plant</surname><given-names>T</given-names></name>, <name><surname>Konnerth</surname><given-names>A</given-names></name>. <article-title>Localized calcium signaling and neuronal integration in cerebellar Purkinje neurones</article-title>. <source>Cell Calcium</source>. <year>1996</year>;<volume>20</volume>: <fpage>215</fpage>&#x2013;<lpage>226</lpage>. <pub-id pub-id-type="pmid">8889210</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref009">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Fletcher</surname><given-names>CF</given-names></name>, <name><surname>Tottene</surname><given-names>A</given-names></name>, <name><surname>Lennon</surname><given-names>VA</given-names></name>, <name><surname>Wilson</surname><given-names>SM</given-names></name>, <name><surname>Dubel</surname><given-names>SJ</given-names></name>, <name><surname>Paylor</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Dystonia and cerebellar atrophy in <italic>Cacna1a</italic> null mice lacking P/Q calcium channel activity</article-title>. <source>FASEB J</source>. <year>2001</year>;<volume>15</volume>: <fpage>1288</fpage>&#x2013;<lpage>1290</lpage>. <pub-id pub-id-type="pmid">11344116</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref010">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Pietrobon</surname><given-names>D</given-names></name>, <name><surname>Striessnig</surname><given-names>J</given-names></name>. <article-title>Neurobiology of migraine</article-title>. <source>Nat Rev Neurosci</source>. <year>2003</year>;<volume>4</volume>: <fpage>386</fpage>&#x2013;<lpage>398</lpage>. <pub-id pub-id-type="pmid">12728266</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref011">
        <label>11</label>
        <mixed-citation publication-type="journal"><name><surname>Pietrobon</surname><given-names>D</given-names></name>. <article-title>Ca<sub>V</sub>2.1 channelopathies</article-title>. <source>Pfl&#xFC;gers Arch&#x2014;Eur J Physiol</source>. <year>2010</year>;<volume>460</volume>: <fpage>375</fpage>&#x2013;<lpage>393</lpage>.<pub-id pub-id-type="pmid">20204399</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref012">
        <label>12</label>
        <mixed-citation publication-type="journal"><name><surname>Pelzer</surname><given-names>N</given-names></name>, <name><surname>Stam</surname><given-names>AH</given-names></name>, <name><surname>Haan</surname><given-names>J</given-names></name>, <name><surname>Ferrari</surname><given-names>MD</given-names></name>, <name><surname>Terwindt</surname><given-names>GM</given-names></name>. <article-title>Familial and sporadic hemiplegic migraine: diagnosis and treatment</article-title>. <source>Curr Treat Options Neurol</source>. <year>2013</year>;<volume>15</volume>: <fpage>13</fpage>&#x2013;<lpage>27</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s11940-012-0208-3">10.1007/s11940-012-0208-3</ext-link></comment>
<pub-id pub-id-type="pmid">23203776</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref013">
        <label>13</label>
        <mixed-citation publication-type="journal"><name><surname>Serra</surname><given-names>SA</given-names></name>, <name><surname>Fern&#xE0;ndez-Castillo</surname><given-names>N</given-names></name>, <name><surname>Macaya</surname><given-names>A</given-names></name>, <name><surname>Cormand</surname><given-names>B</given-names></name>, <name><surname>Valverde</surname><given-names>MA</given-names></name>, <name><surname>Fern&#xE1;ndez-Fern&#xE1;ndez</surname><given-names>JM</given-names></name>. <article-title>The Hemiplegic Migraine associated Y1245C mutation in CACNA1A results in a gain of channel function due to its effect on the voltage sensor and G-protein mediated inhibition</article-title>. <source>Pfl&#xFC;gers Arch&#x2014;Eur J Physiol</source>. <year>2009</year>;<volume>458</volume>: <fpage>489</fpage>&#x2013;<lpage>502</lpage>.<pub-id pub-id-type="pmid">19189122</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref014">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Carre&#xF1;o</surname><given-names>O</given-names></name>, <name><surname>Corominas</surname><given-names>R</given-names></name>, <name><surname>Serra</surname><given-names>SA</given-names></name>, <name><surname>Sintas</surname><given-names>C</given-names></name>, <name><surname>Fern&#xE1;ndez-Castillo</surname><given-names>N</given-names></name>, <name><surname>Vila-Pueyo</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Screening of <italic>CACNA1A</italic> and <italic>ATP1A2</italic> genes in hemiplegic migraine: clinical, genetic, and functional studies</article-title>. <source>Mol Genet &amp; Genomic Med</source>. <year>2013</year>;<volume>1</volume>: <fpage>206</fpage>&#x2013;<lpage>222</lpage>.<pub-id pub-id-type="pmid">24498617</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref015">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>Vecchia</surname><given-names>D</given-names></name>, <name><surname>Tottene</surname><given-names>A</given-names></name>, <name><surname>van den Maagdenberg</surname><given-names>AMJM</given-names></name>, <name><surname>Pietrobon</surname><given-names>D</given-names></name>. <article-title>Mechanism underlying unaltered cortical inhibitory synaptic transmission in contrast with enhanced excitatory transmission in Ca<sub>V</sub>2.1 knockin migraine mice</article-title>. <source>Neurobiol Dis</source>. <year>2014</year>;<volume>69</volume>: <fpage>225</fpage>&#x2013;<lpage>234</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.nbd.2014.05.035">10.1016/j.nbd.2014.05.035</ext-link></comment>
<pub-id pub-id-type="pmid">24907493</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref016">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>van den Maagdenberg</surname><given-names>AMJM</given-names></name>, <name><surname>Pietrobon</surname><given-names>D</given-names></name>, <name><surname>Pizzorusso</surname><given-names>T</given-names></name>, <name><surname>Kaja</surname><given-names>S</given-names></name>, <name><surname>Broos</surname><given-names>LA</given-names></name>, <name><surname>Cesetti</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>A <italic>Cacna1a</italic> knockin migraine mouse model with increased susceptibility to cortical spreading depression</article-title>. <source>Neuron</source>. <year>2004</year>;<volume>41</volume>: <fpage>701</fpage>&#x2013;<lpage>710</lpage>. <pub-id pub-id-type="pmid">15003170</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref017">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Tottene</surname><given-names>A</given-names></name>, <name><surname>Conti</surname><given-names>R</given-names></name>, <name><surname>Fabbro</surname><given-names>A</given-names></name>, <name><surname>Vecchia</surname><given-names>D</given-names></name>, <name><surname>Shapovalova</surname><given-names>M</given-names></name>, <name><surname>Santello</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca<sub>V</sub>2.1 knockin migraine mice</article-title>. <source>Neuron</source>. <year>2009</year>;<volume>61</volume>: <fpage>762</fpage>&#x2013;<lpage>773</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuron.2009.01.027">10.1016/j.neuron.2009.01.027</ext-link></comment>
<pub-id pub-id-type="pmid">19285472</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref018">
        <label>18</label>
        <mixed-citation publication-type="journal"><name><surname>Di Guilmi</surname><given-names>MN</given-names></name>, <name><surname>Wang</surname><given-names>T</given-names></name>, <name><surname>Inchauspe</surname><given-names>CG</given-names></name>, <name><surname>Forsythe</surname><given-names>ID</given-names></name>, <name><surname>Ferrari</surname><given-names>MD</given-names></name>, <name><surname>van den Maagdenberg</surname><given-names>AMJM</given-names></name>, <etal>et al</etal>
<article-title>Synaptic gain-of-function effects of mutant Ca<sub>V</sub>2.1 channels in a mouse model of familial hemiplegic migraine are due to increased basal [Ca<sup>2+</sup>]<sub>i</sub></article-title>. <source>J Neurosci</source>. <year>2014</year>;<volume>34</volume>: <fpage>7047</fpage>&#x2013;<lpage>7058</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1523/JNEUROSCI.2526-13.2014">10.1523/JNEUROSCI.2526-13.2014</ext-link></comment>
<pub-id pub-id-type="pmid">24849341</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref019">
        <label>19</label>
        <mixed-citation publication-type="journal"><name><surname>Bolay</surname><given-names>H</given-names></name>, <name><surname>Reuter</surname><given-names>U</given-names></name>, <name><surname>Dunn</surname><given-names>AK</given-names></name>, <name><surname>Huang</surname><given-names>Z</given-names></name>, <name><surname>Boas</surname><given-names>DA</given-names></name>, <name><surname>Moskowitz</surname><given-names>MA</given-names></name>. <article-title>Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model</article-title>. <source>Nat Med</source>. <year>2002</year>;<volume>8</volume>: <fpage>136</fpage>&#x2013;<lpage>142</lpage>. <pub-id pub-id-type="pmid">11821897</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref020">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Pietrobon</surname><given-names>D</given-names></name>, <name><surname>Moskowitz</surname><given-names>MA</given-names></name>. <article-title>Pathophysiology of migraine</article-title>. <source>Annu Rev Physiol</source>. <year>2013</year>;<volume>75</volume>: <fpage>365</fpage>&#x2013;<lpage>391</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev-physiol-030212-183717">10.1146/annurev-physiol-030212-183717</ext-link></comment>
<pub-id pub-id-type="pmid">23190076</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref021">
        <label>21</label>
        <mixed-citation publication-type="journal"><name><surname>Cuenca-Le&#xF3;n</surname><given-names>E</given-names></name>, <name><surname>Banchs</surname><given-names>I</given-names></name>, <name><surname>Serra</surname><given-names>SA</given-names></name>, <name><surname>Latorre</surname><given-names>P</given-names></name>, <name><surname>Fern&#xE0;ndez-Castillo</surname><given-names>N</given-names></name>, <name><surname>Corominas</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Late-Onset Episodic Ataxia Type 2 associated with a novel loss-of-function mutation in the <italic>CACNA1A</italic> gene</article-title>. <source>J Neurol Sci</source>. <year>2009</year>;<volume>28</volume>: <fpage>10</fpage>&#x2013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">19232643</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref022">
        <label>22</label>
        <mixed-citation publication-type="journal"><name><surname>Strupp</surname><given-names>M</given-names></name>, <name><surname>Zwergal</surname><given-names>A</given-names></name>, <name><surname>Brandt</surname><given-names>T</given-names></name>. <article-title>Episodic ataxia type 2</article-title>. <source>Neurotherapeutics</source>. <year>2007</year>;<volume>4</volume>: <fpage>267</fpage>&#x2013;<lpage>273</lpage>. <pub-id pub-id-type="pmid">17395137</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref023">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>Scoggan</surname><given-names>KA</given-names></name>, <name><surname>Friedman</surname><given-names>JH</given-names></name>, <name><surname>Bulman</surname><given-names>DE</given-names></name>. <article-title><italic>CACNA1A mu</italic>tation in a EA-2 patient responsive to acetazolamide and valproic acid</article-title>. <source>Can J Neurol Sci</source>. <year>2006</year>;<volume>33</volume>: <fpage>68</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="pmid">16583725</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref024">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Rajakulendran</surname><given-names>S</given-names></name>, <name><surname>Graves</surname><given-names>TD</given-names></name>, <name><surname>Labrum</surname><given-names>RW</given-names></name>, <name><surname>Kotzadimitriou</surname><given-names>D</given-names></name>, <name><surname>Eunson</surname><given-names>L</given-names></name>, <name><surname>Davis</surname><given-names>MB</given-names></name>, <etal>et al</etal>
<article-title>Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy</article-title>. <source>J Physiol</source>. <year>2010</year>;<volume>588</volume>: <fpage>1905</fpage>&#x2013;<lpage>1913</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1113/jphysiol.2009.186437">10.1113/jphysiol.2009.186437</ext-link></comment>
<pub-id pub-id-type="pmid">20156848</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref025">
        <label>25</label>
        <mixed-citation publication-type="journal"><name><surname>Imbrici</surname><given-names>P</given-names></name>, <name><surname>Jaffe</surname><given-names>SL</given-names></name>, <name><surname>Eunson</surname><given-names>LH</given-names></name>, <name><surname>Davies</surname><given-names>NP</given-names></name>, <name><surname>Herd</surname><given-names>C</given-names></name>, <name><surname>Robertson</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Dysfunction of the brain calcium channel Ca<sub>V</sub>2.1 in absence epilepsy and episodic ataxia</article-title>. <source>Brain</source>. <year>2004</year>;<volume>127</volume>: <fpage>2682</fpage>&#x2013;<lpage>2692</lpage>. <pub-id pub-id-type="pmid">15483044</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref026">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Vila-Pueyo</surname><given-names>M</given-names></name>, <name><surname>Gen&#xE9;</surname><given-names>GG</given-names></name>, <name><surname>Flotats-Bastardes</surname><given-names>M</given-names></name>, <name><surname>Elorza</surname><given-names>X</given-names></name>, <name><surname>Sintas</surname><given-names>C</given-names></name>, <name><surname>Valverde</surname><given-names>MA</given-names></name>, <etal>et al</etal>
<article-title>A loss-of-function CACNA1A mutation causing benign paroxysmal torticollis of infancy</article-title>
<source>Eur J Paediatr Neurol</source>. <year>2014</year>;<volume>18</volume>: <fpage>430</fpage>&#x2013;<lpage>433</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ejpn.2013.12.011">10.1016/j.ejpn.2013.12.011</ext-link></comment>
<pub-id pub-id-type="pmid">24445160</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref027">
        <label>27</label>
        <mixed-citation publication-type="journal"><name><surname>Mori</surname><given-names>Y</given-names></name>, <name><surname>Wakamori</surname><given-names>M</given-names></name>, <name><surname>Oda</surname><given-names>S</given-names></name>, <name><surname>Fletcher</surname><given-names>CF</given-names></name>, <name><surname>Sekiguchi</surname><given-names>N</given-names></name>, <name><surname>Mori</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Reduced voltage sensitivity of activation of P/Q-type Ca2+ channels is associated with the ataxic mouse mutation Rolling Nagoya (<italic>tg</italic><sup><italic>rol</italic></sup>)</article-title>. <source>J Neurosci</source>. <year>2000</year>;<volume>20</volume>: <fpage>5654</fpage>&#x2013;<lpage>5662</lpage>. <pub-id pub-id-type="pmid">10908603</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref028">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Imbrici</surname><given-names>P</given-names></name>, <name><surname>Eunson</surname><given-names>LH</given-names></name>, <name><surname>Graves</surname><given-names>TD</given-names></name>, <name><surname>Bhatia</surname><given-names>KP</given-names></name>, <name><surname>Wadia</surname><given-names>NH</given-names></name>, <name><surname>Kullmann</surname><given-names>DM</given-names></name>, <etal>et al</etal>
<article-title>Late-onset episodic ataxia type 2 due to an in-frame insertion in <italic>CACNA1A</italic></article-title>. <source>Neurology</source>. <year>2005</year>;<volume>65</volume>: <fpage>944</fpage>&#x2013;<lpage>946</lpage>. <pub-id pub-id-type="pmid">16186543</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref029">
        <label>29</label>
        <mixed-citation publication-type="journal"><name><surname>Spacey</surname><given-names>SD</given-names></name>, <name><surname>Hildebrand</surname><given-names>ME</given-names></name>, <name><surname>Materek</surname><given-names>LA</given-names></name>, <name><surname>Bird</surname><given-names>TD</given-names></name>, <name><surname>Snutch</surname><given-names>TP</given-names></name>. <article-title>Functional implications of a novel EA2 mutation in the P/Q-type calcium channel</article-title>. <source>Ann Neurol</source>. <year>2004</year>;<volume>56</volume>: <fpage>213</fpage>&#x2013;<lpage>220</lpage>. <pub-id pub-id-type="pmid">15293273</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref030">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Wan</surname><given-names>J</given-names></name>, <name><surname>Khanna</surname><given-names>R</given-names></name>, <name><surname>Sandusky</surname><given-names>M</given-names></name>, <name><surname>Papazian</surname><given-names>DM</given-names></name>, <name><surname>Jen</surname><given-names>JC</given-names></name>, <name><surname>Baloh</surname><given-names>RW</given-names></name>. <article-title><italic>CACNA1A</italic> mutations causing episodic and progressive ataxia alter channel trafficking and kinetics</article-title>. <source>Neurology</source>. <year>2005</year>;<volume>64</volume>: <fpage>2090</fpage>&#x2013;<lpage>2097</lpage>. <pub-id pub-id-type="pmid">15985579</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref031">
        <label>31</label>
        <mixed-citation publication-type="journal"><name><surname>Wappl</surname><given-names>E</given-names></name>, <name><surname>Koschak</surname><given-names>A</given-names></name>, <name><surname>Poteser</surname><given-names>M</given-names></name>, <name><surname>Sinnegger</surname><given-names>MJ</given-names></name>, <name><surname>Walter</surname><given-names>D</given-names></name>, <name><surname>Eberhart</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Functional consequences of P/Q-type Ca<sup>2+</sup> channel Ca<sub>V</sub>2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia</article-title>. <source>J Biol Chem</source>. <year>2002</year>;<volume>277</volume>: <fpage>6960</fpage>&#x2013;<lpage>6966</lpage>. <pub-id pub-id-type="pmid">11742003</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref032">
        <label>32</label>
        <mixed-citation publication-type="journal"><name><surname>Cricchi</surname><given-names>F</given-names></name>, <name><surname>Di Lorenzo</surname><given-names>C</given-names></name>, <name><surname>Grieco</surname><given-names>GS</given-names></name>, <name><surname>Rengo</surname><given-names>C</given-names></name>, <name><surname>Cardinale</surname><given-names>A</given-names></name>, <name><surname>Racaniello</surname><given-names>M</given-names></name>, <etal>et al</etal>
<article-title>Early-onset progressive ataxia associated with the first <italic>CACNA1A</italic> mutation identified within the I-II loop</article-title>. <source>J Neurol Sci</source>. <year>2007</year>;<volume>254</volume>: <fpage>69</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="pmid">17292920</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref033">
        <label>33</label>
        <mixed-citation publication-type="journal"><name><surname>Rose</surname><given-names>SJ</given-names></name>, <name><surname>Kriener</surname><given-names>LH</given-names></name>, <name><surname>Heinzer</surname><given-names>AK</given-names></name>, <name><surname>Fan</surname><given-names>X</given-names></name>, <name><surname>Raike</surname><given-names>RS</given-names></name>, <name><surname>van den Maagdenberg</surname><given-names>AMJM</given-names></name>, <etal>et al</etal>
<article-title>The first knockin mouse model of episodic ataxia type 2</article-title>. <source>Exp Neurol</source>. <year>2014</year>;<volume>261C</volume>: <fpage>553</fpage>&#x2013;<lpage>562</lpage>.<pub-id pub-id-type="pmid">25109669</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref034">
        <label>34</label>
        <mixed-citation publication-type="journal"><name><surname>Zhuchenko</surname><given-names>O</given-names></name>, <name><surname>Bailey</surname><given-names>J</given-names></name>, <name><surname>Bonnen</surname><given-names>P</given-names></name>, <name><surname>Ashizawa</surname><given-names>T</given-names></name>, <name><surname>Stockton</surname><given-names>DW</given-names></name>, <name><surname>Amos</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the &#x3B1;<sub>1A</sub>-voltage-dependent calcium channel</article-title>. <source>Nature Genet</source>. <year>1997</year>;<volume>15</volume>: <fpage>62</fpage>&#x2013;<lpage>69</lpage>. <pub-id pub-id-type="pmid">8988170</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref035">
        <label>35</label>
        <mixed-citation publication-type="journal"><name><surname>Watase</surname><given-names>K</given-names></name>, <name><surname>Barrett</surname><given-names>CF</given-names></name>, <name><surname>Miyazaki</surname><given-names>T</given-names></name>, <name><surname>Ishiguro</surname><given-names>T</given-names></name>, <name><surname>Ishikawa</surname><given-names>K</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Spinocerebellar ataxia type 6 knock in mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant Ca<sub>V</sub>2.1 channels</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2008</year>;<volume>105</volume>: <fpage>11987</fpage>&#x2013;<lpage>11992</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0804350105">10.1073/pnas.0804350105</ext-link></comment>
<pub-id pub-id-type="pmid">18687887</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref036">
        <label>36</label>
        <mixed-citation publication-type="journal"><name><surname>Fitzsimons</surname><given-names>RB</given-names></name>, <name><surname>Wolfenden</surname><given-names>WH</given-names></name>. <article-title>Migraine coma: meningitic migraine with cerebral oedema associated with a new form of autosomal dominant cerebellar ataxia</article-title>. <source>Brain</source>. <year>1985</year>;<volume>108</volume>: <fpage>555</fpage>&#x2013;<lpage>577</lpage>. <pub-id pub-id-type="pmid">4041774</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref037">
        <label>37</label>
        <mixed-citation publication-type="journal"><name><surname>Kors</surname><given-names>EE</given-names></name>, <name><surname>Terwindt</surname><given-names>GM</given-names></name>, <name><surname>Vermeulen</surname><given-names>FL</given-names></name>, <name><surname>Fitzsimons</surname><given-names>RB</given-names></name>, <name><surname>Jardine</surname><given-names>PE</given-names></name>, <name><surname>Heywood</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Delayed cerebral edema and fatal coma after minor head trauma: role of the <italic>CACNA1A</italic> calcium channel subunit gene and relationship with familial hemiplegic migraine</article-title>. <source>Ann Neurol</source>. <year>2001</year>;<volume>49</volume>: <fpage>753</fpage>&#x2013;<lpage>760</lpage>. <pub-id pub-id-type="pmid">11409427</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref038">
        <label>38</label>
        <mixed-citation publication-type="journal"><name><surname>Terwindt</surname><given-names>GM</given-names></name>, <name><surname>Ophoff</surname><given-names>RA</given-names></name>, <name><surname>Haan</surname><given-names>J</given-names></name>, <name><surname>Vergouwe</surname><given-names>MN</given-names></name>, <name><surname>van Eijk</surname><given-names>R</given-names></name>, <name><surname>Frants</surname><given-names>RR</given-names></name>, <etal>et al</etal>
<article-title>Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group</article-title>. <source>Neurology</source>. <year>1998</year>;<volume>50</volume>: <fpage>1105</fpage>&#x2013;<lpage>1110</lpage>. <pub-id pub-id-type="pmid">9566402</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref039">
        <label>39</label>
        <mixed-citation publication-type="journal"><name><surname>Ducros</surname><given-names>A</given-names></name>, <name><surname>Denier</surname><given-names>C</given-names></name>, <name><surname>Joutel</surname><given-names>A</given-names></name>, <name><surname>Vahedi</surname><given-names>K</given-names></name>, <name><surname>Michel</surname><given-names>A</given-names></name>, <name><surname>Darcel</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Recurrence of the T666M calcium channel <italic>CACNA1A</italic> gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia</article-title>. <source>Am J Hum Genet</source>. <year>1999</year>;<volume>64</volume>:<fpage>89</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="pmid">9915947</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref040">
        <label>40</label>
        <mixed-citation publication-type="journal"><name><surname>Wada</surname><given-names>T</given-names></name>, <name><surname>Kobayashi</surname><given-names>N</given-names></name>, <name><surname>Takahashi</surname><given-names>Y</given-names></name>, <name><surname>Aoki</surname><given-names>T</given-names></name>, <name><surname>Watanabe</surname><given-names>T</given-names></name>, <name><surname>Saitoh</surname><given-names>S</given-names></name>. <article-title>Wide clinical variability in a family with a CACNA1A T666M mutation. Hemiplegic coma and progressive ataxia</article-title>. <source>Pediatr Neurol</source>. <year>2002</year>;<volume>26</volume>: <fpage>47</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="pmid">11814735</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref041">
        <label>41</label>
        <mixed-citation publication-type="journal"><name><surname>Blumkin</surname><given-names>L</given-names></name>, <name><surname>Michelson</surname><given-names>M</given-names></name>, <name><surname>Leshinsky-Silver</surname><given-names>E</given-names></name>, <name><surname>Kivity</surname><given-names>S</given-names></name>, <name><surname>Lev</surname><given-names>D</given-names></name>, <name><surname>Lerman-Sagie</surname><given-names>T</given-names></name>. <article-title>Congenital ataxia, mental retardation, and dyskinesia associated with a novel CACNA1A mutation</article-title>. <source>J Child Neurol</source>. <year>2010</year>;<volume>25</volume>:<fpage>892</fpage>&#x2013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1177/0883073809351316">10.1177/0883073809351316</ext-link></comment>
<pub-id pub-id-type="pmid">20097664</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref042">
        <label>42</label>
        <mixed-citation publication-type="journal"><name><surname>Knierim</surname><given-names>E</given-names></name>, <name><surname>Leisle</surname><given-names>L</given-names></name>, <name><surname>Wagner</surname><given-names>C</given-names></name>, <name><surname>Weschke</surname><given-names>B</given-names></name>, <name><surname>Lucke</surname><given-names>B</given-names></name>, <name><surname>Bohner</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Recurrent stroke due to a novel voltage sensor mutation in Cav2.1 responds to verapamil</article-title>. <source>Stroke</source>. <year>2011</year>;<volume>42</volume>: <fpage>e14</fpage>&#x2013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1161/STROKEAHA.110.600023">10.1161/STROKEAHA.110.600023</ext-link></comment>
<pub-id pub-id-type="pmid">21183743</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref043">
        <label>43</label>
        <mixed-citation publication-type="journal"><name><surname>Naik</surname><given-names>S</given-names></name>, <name><surname>Pohl</surname><given-names>K</given-names></name>, <name><surname>Malik</surname><given-names>M</given-names></name>, <name><surname>Siddiqui</surname><given-names>A</given-names></name>, <name><surname>Josifova</surname><given-names>D</given-names></name>. <article-title>Early-onset cerebellar atrophy associated with mutation in the <italic>CACNA1A</italic> gene</article-title>. <source>Pediatr Neurol</source>. <year>2011</year>;<volume>45</volume>: <fpage>328</fpage>&#x2013;<lpage>330</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.pediatrneurol.2011.08.002">10.1016/j.pediatrneurol.2011.08.002</ext-link></comment>
<pub-id pub-id-type="pmid">22000314</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref044">
        <label>44</label>
        <mixed-citation publication-type="journal"><name><surname>Garc&#xED;a-Segarra</surname><given-names>N</given-names></name>, <name><surname>Gautschi</surname><given-names>I</given-names></name>, <name><surname>Mittaz-Crettol</surname><given-names>L</given-names></name>, <name><surname>Kallay Zetchi</surname><given-names>C</given-names></name>, <name><surname>Al-Qusairi</surname><given-names>L</given-names></name>, <name><surname>Van Bemmelen</surname><given-names>MX</given-names></name>, <etal>et al</etal>
<article-title>Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A</article-title>. <source>J Neurol Sci</source>. <year>2014</year>;<volume>342</volume>: <fpage>69</fpage>&#x2013;<lpage>78</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jns.2014.04.027">10.1016/j.jns.2014.04.027</ext-link></comment>
<pub-id pub-id-type="pmid">24836863</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref045">
        <label>45</label>
        <mixed-citation publication-type="journal"><name><surname>DePristo</surname><given-names>MA</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Poplin</surname><given-names>R</given-names></name>, <name><surname>Garimella</surname><given-names>KV</given-names></name>, <name><surname>Maguire</surname><given-names>JR</given-names></name>, <name><surname>Hartl</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>A framework for variation discovery and genotyping using next-generation DNA sequencing data</article-title>. <source>Nat Genet</source>. <year>2011</year>;<volume>43</volume>: <fpage>491</fpage>&#x2013;<lpage>498</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.806">10.1038/ng.806</ext-link></comment>
<pub-id pub-id-type="pmid">21478889</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref046">
        <label>46</label>
        <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>H</given-names></name>. <article-title>Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM</article-title>. <source>arXiv</source>
<year>2013</year>;<volume>00</volume>(<issue>00</issue>): <fpage>1</fpage>&#x2013;<lpage>3</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0146035.ref047">
        <label>47</label>
        <mixed-citation publication-type="journal"><name><surname>Ossowski</surname><given-names>S</given-names></name>, <name><surname>Schneeberger</surname><given-names>K</given-names></name>, <name><surname>Clark</surname><given-names>RM</given-names></name>, <name><surname>Lanz</surname><given-names>C</given-names></name>, <name><surname>Warthmann</surname><given-names>N</given-names></name>, <name><surname>Weigel</surname><given-names>D</given-names></name>. <article-title>Sequencing of natural strains of <italic>Arabidopsis thaliana</italic> with short reads</article-title>. <source>Genome Res</source>. <year>2008</year>; <volume>18</volume>: <fpage>2024</fpage>&#x2013;<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1101/gr.080200.108">10.1101/gr.080200.108</ext-link></comment>
<pub-id pub-id-type="pmid">18818371</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref048">
        <label>48</label>
        <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>K</given-names></name>, <name><surname>Li</surname><given-names>M</given-names></name>, <name><surname>Hakonarson</surname><given-names>H</given-names></name>. <article-title>ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data</article-title>. <source>Nucleic Acids Res</source>. <year>2010</year>;<volume>38</volume>: <fpage>e164</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkq603">10.1093/nar/gkq603</ext-link></comment>
<pub-id pub-id-type="pmid">20601685</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref049">
        <label>49</label>
        <mixed-citation publication-type="journal"><name><surname>Adzhubei</surname><given-names>IA</given-names></name>, <name><surname>Schmidt</surname><given-names>S</given-names></name>, <name><surname>Peshkin</surname><given-names>L</given-names></name>, <name><surname>Ramensky</surname><given-names>VE</given-names></name>, <name><surname>Gerasimova</surname><given-names>A</given-names></name>, <name><surname>Bork</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>A method and server for predicting damaging missense mutations</article-title>. <source>Nat Methods</source>. <year>2010</year>;<volume>7</volume>: <fpage>248</fpage>&#x2013;<lpage>249</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nmeth0410-248">10.1038/nmeth0410-248</ext-link></comment>
<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref050">
        <label>50</label>
        <mixed-citation publication-type="journal"><name><surname>Ng</surname><given-names>PC</given-names></name>, <name><surname>Henikoff</surname><given-names>S</given-names></name>. <article-title>SIFT: predicting amino acid changes that affect protein function</article-title>. <source>Nucleic Acids Res</source>. <year>2003</year>;<volume>31</volume>: <fpage>3812</fpage>&#x2013;<lpage>3814</lpage>. <pub-id pub-id-type="pmid">12824425</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref051">
        <label>51</label>
        <mixed-citation publication-type="journal"><name><surname>Gonz&#xE1;lez-P&#xE9;rez</surname><given-names>A</given-names></name>, <name><surname>L&#xF3;pez-Bigas</surname><given-names>N</given-names></name>. <article-title>Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel</article-title>. <source>Am J Hum Genet</source>. <year>2011</year>;<volume>88</volume>: <fpage>440</fpage>&#x2013;<lpage>449</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ajhg.2011.03.004">10.1016/j.ajhg.2011.03.004</ext-link></comment>
<pub-id pub-id-type="pmid">21457909</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref052">
        <label>52</label>
        <mixed-citation publication-type="journal"><name><surname>Kircher</surname><given-names>M</given-names></name>, <name><surname>Witten</surname><given-names>DM</given-names></name>, <name><surname>Jain</surname><given-names>P</given-names></name>, <name><surname>O&#xB4;Roak</surname><given-names>BJ</given-names></name>, <name><surname>Cooper</surname><given-names>GM</given-names></name>, <name><surname>Shendure</surname><given-names>J</given-names></name>. <article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>. <source>Nat Genet</source>. <year>2014</year>;<volume>46</volume>: <fpage>310</fpage>&#x2013;<lpage>315</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ng.2892">10.1038/ng.2892</ext-link></comment>
<pub-id pub-id-type="pmid">24487276</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref053">
        <label>53</label>
        <mixed-citation publication-type="journal"><name><surname>Margulies</surname><given-names>EH</given-names></name>, <name><surname>Blanchette</surname><given-names>M</given-names></name>, <collab>NISC Comparative Sequencing Program</collab>, <name><surname>Haussler</surname><given-names>D</given-names></name>,<name><surname>Green</surname><given-names>ED</given-names></name>. <article-title>Identification and characterization of multi-species conserved sequences</article-title>, <source>Genome Res</source>. <year>2003</year>;<volume>13</volume>: <fpage>2507</fpage>&#x2013;<lpage>2518</lpage>. <pub-id pub-id-type="pmid">14656959</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref054">
        <label>54</label>
        <mixed-citation publication-type="journal"><name><surname>Tranchevent</surname><given-names>LC</given-names></name>, <name><surname>Barriot</surname><given-names>R</given-names></name>, <name><surname>Yu</surname><given-names>S</given-names></name>, <name><surname>Van Vooren</surname><given-names>S</given-names></name>, <name><surname>Van Loo</surname><given-names>P</given-names></name>, <name><surname>Coessens</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>ENDEAVOUR update: a web resource for gene prioritization in multiple species</article-title>. <source>Nucleic Acids Res</source>. <year>2008</year>;<volume>36</volume>(<issue>Web Server issue</issue>): <fpage>W377</fpage>&#x2013;<lpage>384</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/nar/gkn325">10.1093/nar/gkn325</ext-link></comment>
<pub-id pub-id-type="pmid">18508807</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref055">
        <label>55</label>
        <mixed-citation publication-type="journal"><name><surname>Hamosh</surname><given-names>AA</given-names></name>, <name><surname>Scott</surname><given-names>F</given-names></name>, <name><surname>Amberger</surname><given-names>JS</given-names></name>, <name><surname>Bocchini</surname><given-names>CA</given-names></name>, <name><surname>McKusick</surname><given-names>VA</given-names></name>. <article-title>Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders</article-title>. <source>Nucleic Acids Res</source>. <year>2005</year>;<volume>33</volume>(<issue>Database issue</issue>): <fpage>D514</fpage>&#x2013;<lpage>517</lpage>. <pub-id pub-id-type="pmid">15608251</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref056">
        <label>56</label>
        <mixed-citation publication-type="journal"><name><surname>Kaplan</surname><given-names>JC</given-names></name>, <name><surname>Hamroun</surname><given-names>D</given-names></name>. <article-title>The 2014 version of the gene table of monogenic neuromuscular disorders (nuclear genome)</article-title>. <source>Neuromuscul Disord</source>. <year>2013</year>;<volume>23</volume>: <fpage>1081</fpage>&#x2013;<lpage>1111</lpage>. <pub-id pub-id-type="pmid">24446552</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref057">
        <label>57</label>
        <mixed-citation publication-type="journal"><name><surname>Pattillo</surname><given-names>JM</given-names></name>, <name><surname>Artim</surname><given-names>DE</given-names></name>, <name><surname>Simples</surname><given-names>JE</given-names><suffix>Jr</suffix></name>, <name><surname>Meriney</surname><given-names>SD</given-names></name>. <article-title>Variations in onset of action potential broadening: effects on calcium current studied in chick ciliary ganglion neurones</article-title>. <source>J Physiol</source>. <year>1999</year>;<volume>514</volume>: <fpage>719</fpage>&#x2013;<lpage>728</lpage>. <pub-id pub-id-type="pmid">9882744</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref058">
        <label>58</label>
        <mixed-citation publication-type="journal"><name><surname>Oelstrom</surname><given-names>K</given-names></name>, <name><surname>Goldschen-Ohm</surname><given-names>MP</given-names></name>, <name><surname>Holmgren</surname><given-names>M</given-names></name>, <name><surname>Chanda</surname><given-names>B</given-names></name>. <article-title>Evolutionarily conserved intracellular gate of voltage-dependent sodium channels</article-title>. <source>Nat Commun</source>. <year>2014</year>;<volume>5</volume>: <fpage>3420</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms4420">10.1038/ncomms4420</ext-link></comment>
<pub-id pub-id-type="pmid">24619022</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref059">
        <label>59</label>
        <mixed-citation publication-type="journal"><name><surname>Zhong</surname><given-names>H</given-names></name>, <name><surname>Yokoyama</surname><given-names>CT</given-names></name>, <name><surname>Scheuer</surname><given-names>T</given-names></name>, <name><surname>Catterall</surname><given-names>WA</given-names></name>. <article-title>Reciprocal regulation of P/Q type Ca<sup>2+</sup> channels by SNAP-25, syntaxin and synaptotagmin</article-title>. <source>Nat Neurosci</source>. <year>1999</year>;<volume>2</volume>: <fpage>939</fpage>&#x2013;<lpage>941</lpage>. <pub-id pub-id-type="pmid">10526329</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref060">
        <label>60</label>
        <mixed-citation publication-type="journal"><name><surname>Kraus</surname><given-names>RL</given-names></name>, <name><surname>Sinnegger</surname><given-names>MJ</given-names></name>, <name><surname>Koschak</surname><given-names>A</given-names></name>, <name><surname>Glossmann</surname><given-names>H</given-names></name>, <name><surname>Stenirri</surname><given-names>S</given-names></name>, <name><surname>Carrera</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Three new familial hemiplegic migraine mutants affect P/Q-type Ca<sup>2+</sup> channel kinetics</article-title>. <source>J Biol Chem</source>. <year>2000</year>;<volume>275</volume>: <fpage>9239</fpage>&#x2013;<lpage>9243</lpage>. <pub-id pub-id-type="pmid">10734061</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref061">
        <label>61</label>
        <mixed-citation publication-type="journal"><name><surname>Pietrobon</surname><given-names>D</given-names></name>. <article-title>Familial hemiplegic migraine</article-title>. <source>Neurotherapeutics</source>
<year>2007</year>;<volume>4</volume>: <fpage>274</fpage>&#x2013;<lpage>284</lpage>. <pub-id pub-id-type="pmid">17395138</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref062">
        <label>62</label>
        <mixed-citation publication-type="journal"><name><surname>Tottene</surname><given-names>A</given-names></name>, <name><surname>Pivotto</surname><given-names>F</given-names></name>, <name><surname>Fellin</surname><given-names>T</given-names></name>, <name><surname>Cesetti</surname><given-names>T</given-names></name>, <name><surname>van den Maagdenberg</surname><given-names>AMJM</given-names></name>, <name><surname>Pietrobon</surname><given-names>D</given-names></name>. <article-title>Specific kinetic alterations of human Ca<sub>V</sub>2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma</article-title>. <source>J Biol Chem</source>. <year>2005</year>;<volume>280</volume>: <fpage>17678</fpage>&#x2013;<lpage>17686</lpage>. <pub-id pub-id-type="pmid">15743764</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref063">
        <label>63</label>
        <mixed-citation publication-type="journal"><name><surname>Kraus</surname><given-names>RL</given-names></name>, <name><surname>Sinnegger</surname><given-names>MJ</given-names></name>, <name><surname>Glossmann</surname><given-names>H</given-names></name>, <name><surname>Hering</surname><given-names>S</given-names></name>, <name><surname>Striessnig</surname><given-names>J</given-names></name>. <article-title>Familial hemiplegic migraine mutations change &#x3B1;<sub>1A</sub> Ca<sup>2+</sup> channel kinetics</article-title>. <source>J Biol Chem</source>. <year>1998</year>;<volume>273</volume>: <fpage>5586</fpage>&#x2013;<lpage>5590</lpage>. <pub-id pub-id-type="pmid">9488686</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref064">
        <label>64</label>
        <mixed-citation publication-type="journal"><name><surname>Miki</surname><given-names>T</given-names></name>, <name><surname>Zwingman</surname><given-names>TA</given-names></name>, <name><surname>Wakamori</surname><given-names>M</given-names></name>, <name><surname>Lutz</surname><given-names>CM</given-names></name>, <name><surname>Cook</surname><given-names>SA</given-names></name>, <name><surname>Hosford</surname><given-names>DA</given-names></name>, <etal>et al</etal>
<article-title>Two novel alleles of tottering with distinct Ca<sub>V</sub>2.1 calcium channel neuropathologies</article-title>. <source>Neuroscience</source>. <year>2008</year>;<volume>155</volume>:<fpage>31</fpage>&#x2013;<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuroscience.2008.05.028">10.1016/j.neuroscience.2008.05.028</ext-link></comment>
<pub-id pub-id-type="pmid">18597946</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref065">
        <label>65</label>
        <mixed-citation publication-type="journal"><name><surname>Fioretti</surname><given-names>B</given-names></name>, <name><surname>Catacuzzeno</surname><given-names>L</given-names></name>, <name><surname>Sforna</surname><given-names>L</given-names></name>, <name><surname>Gerke-Duncan</surname><given-names>MB</given-names></name>, <name><surname>van denMaagdenberg</surname><given-names>AMJM</given-names></name>, <name><surname>Franciolini</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Trigeminal ganglion neuron subtype-specific alterations of Ca<sub>V</sub>2.1 calcium current and excitability in a <italic>Cacna1a</italic> mouse model of migraine</article-title>. <source>J Physiol</source>. <year>2011</year>;<volume>589</volume>: <fpage>5879</fpage>&#x2013;<lpage>5895</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1113/jphysiol.2011.220533">10.1113/jphysiol.2011.220533</ext-link></comment>
<pub-id pub-id-type="pmid">22005682</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref066">
        <label>66</label>
        <mixed-citation publication-type="journal"><name><surname>van den Maagdenberg</surname><given-names>AMJM</given-names></name>, <name><surname>Pizzorusso</surname><given-names>T</given-names></name>, <name><surname>Kaja</surname><given-names>S</given-names></name>, <name><surname>Terpolilli</surname><given-names>N</given-names></name>, <name><surname>Shapovalova</surname><given-names>M</given-names></name>, <name><surname>Hoebeek</surname><given-names>FE</given-names></name>, <etal>et al</etal>
<article-title>High cortical spreading depression susceptibility and migraine-associated symptoms in Ca<sub>V</sub>2.1 S218L mice</article-title>. <source>Ann Neurol</source>. <year>2010</year>;<volume>67</volume>: <fpage>85</fpage>&#x2013;<lpage>98</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ana.21815">10.1002/ana.21815</ext-link></comment>
<pub-id pub-id-type="pmid">20186955</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref067">
        <label>67</label>
        <mixed-citation publication-type="journal"><name><surname>Kasumu</surname><given-names>A</given-names></name>, <name><surname>Bezprozvanny</surname><given-names>I</given-names></name>. <article-title>Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias</article-title>. <source>Cerebellum</source>. <year>2012</year>;<volume>11</volume>: <fpage>630</fpage>&#x2013;<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s12311-010-0182-9">10.1007/s12311-010-0182-9</ext-link></comment>
<pub-id pub-id-type="pmid">20480274</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref068">
        <label>68</label>
        <mixed-citation publication-type="journal"><name><surname>Turkmen</surname><given-names>S</given-names></name>, <name><surname>Guo</surname><given-names>G</given-names></name>, <name><surname>Garshasbi</surname><given-names>M</given-names></name>, <name><surname>Hoffmann</surname><given-names>K</given-names></name>, <name><surname>Alshalah</surname><given-names>AJ</given-names></name>, <name><surname>Mischung</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>CA8 mutations cause a novel syndrome characterized by ataxia and mild mental retardation with predisposition to quadrupedal gait</article-title>. <source>PLoS Genet</source>. <year>2009</year>;<volume>5</volume>(<issue>5</issue>): <fpage>e1000487</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pgen.1000487">10.1371/journal.pgen.1000487</ext-link></comment>
<pub-id pub-id-type="pmid">19461874</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref069">
        <label>69</label>
        <mixed-citation publication-type="journal"><name><surname>Kaya</surname><given-names>N</given-names></name>, <name><surname>Aldhalaan</surname><given-names>H</given-names></name>, <name><surname>Al-Younes</surname><given-names>B</given-names></name>, <name><surname>Colak</surname><given-names>D</given-names></name>, <name><surname>Shuaib</surname><given-names>T</given-names></name>, <name><surname>Al-Mohaileb</surname><given-names>F</given-names></name>, <etal>et al</etal>
<article-title>Phenotypical spectrum of cerebellar ataxia associated with a novel mutation in the <italic>CA8</italic> gene, encoding carbonic anhydrase (CA) VIII</article-title>. <source>Am J Med Genet Part B</source>. <year>2011</year>;<volume>156</volume>: <fpage>826</fpage>&#x2013;<lpage>834</lpage>.<pub-id pub-id-type="pmid">21812104</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref070">
        <label>70</label>
        <mixed-citation publication-type="journal"><name><surname>Hirota</surname><given-names>J</given-names></name>, <name><surname>Ando</surname><given-names>H</given-names></name>, <name><surname>Hamada</surname><given-names>K</given-names></name>, <name><surname>Mikoshiba</surname><given-names>K</given-names></name>. <article-title>Carbonic anhydrase-related protein is a novel binding protein for inositol 1,4,5-trisphosphate receptor type 1</article-title>. <source>Biochem J</source>. <year>2003</year>;<volume>372</volume>: <fpage>435</fpage>&#x2013;<lpage>441</lpage>. <pub-id pub-id-type="pmid">12611586</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref071">
        <label>71</label>
        <mixed-citation publication-type="journal"><name><surname>Mikoshiba</surname><given-names>K.</given-names></name>
<article-title>IP<sub>3</sub> receptor/Ca<sup>2+</sup> channel: from discovery to new signaling concepts</article-title>. <source>J Neurochem</source>. <year>2007</year>;<volume>102</volume>: <fpage>1426</fpage>&#x2013;<lpage>1446</lpage>. <pub-id pub-id-type="pmid">17697045</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref072">
        <label>72</label>
        <mixed-citation publication-type="journal"><name><surname>Sotelo</surname><given-names>C</given-names></name>, <name><surname>Hillman</surname><given-names>DE</given-names></name>, <name><surname>Zamora</surname><given-names>AJ</given-names></name>, <name><surname>Llinas</surname><given-names>R</given-names></name>. <article-title>Climbing fiber deafferentation: its action on Purkinje cell dendritic spines</article-title>. <source>Brain Res</source>. <year>1975</year>;<volume>98</volume>: <fpage>574</fpage>&#x2013;<lpage>581</lpage>. <pub-id pub-id-type="pmid">1182538</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref073">
        <label>73</label>
        <mixed-citation publication-type="journal"><name><surname>Bravin</surname><given-names>M</given-names></name>, <name><surname>Morando</surname><given-names>L</given-names></name>, <name><surname>Vercelli</surname><given-names>A</given-names></name>, <name><surname>Rossi</surname><given-names>F</given-names></name>, <name><surname>Strata</surname><given-names>P</given-names></name>. <article-title>Control of spine formation by electrical activity in the adult rat cerebellum</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>1999</year>;<volume>96</volume>:<fpage>1704</fpage>&#x2013;<lpage>1709</lpage>. <pub-id pub-id-type="pmid">9990088</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref074">
        <label>74</label>
        <mixed-citation publication-type="journal"><name><surname>Jiao</surname><given-names>Y</given-names></name>, <name><surname>Yan</surname><given-names>J</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Donahue</surname><given-names>LR</given-names></name>, <name><surname>Beamer</surname><given-names>WG</given-names></name>, <etal>et al</etal>
<article-title>Carbonic anhydrase-related protein VIII deficiency is associated with a distinctive lifelong gait disorder in waddles mice</article-title>. <source>Genetics</source>. <year>2005</year>;<volume>171</volume>: <fpage>1239</fpage>&#x2013;<lpage>1246</lpage>. <pub-id pub-id-type="pmid">16118194</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref075">
        <label>75</label>
        <mixed-citation publication-type="journal"><name><surname>Hirasawa</surname><given-names>M</given-names></name>, <name><surname>Xu</surname><given-names>X</given-names></name>, <name><surname>Trask</surname><given-names>RB</given-names></name>, <name><surname>Maddatu</surname><given-names>TP</given-names></name>, <name><surname>Johnson</surname><given-names>BA</given-names></name>, <name><surname>Naggert</surname><given-names>JK</given-names></name>, <etal>et al</etal>
<article-title>Carbonic anhydrase related protein 8 mutation results in aberrant synaptic morphology and excitatory synaptic function in the cerebellum</article-title>. <source>Mol Cell Neurosci</source>. <year>2007</year>;<volume>35</volume>: <fpage>161</fpage>&#x2013;<lpage>170</lpage>. <pub-id pub-id-type="pmid">17376701</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref076">
        <label>76</label>
        <mixed-citation publication-type="journal"><name><surname>Aspatwar</surname><given-names>A</given-names></name>, <name><surname>Tolvanen</surname><given-names>MEE</given-names></name>, <name><surname>Jokitalo</surname><given-names>E</given-names></name>, <name><surname>Parikka</surname><given-names>M</given-names></name>, <name><surname>Ortutay</surname><given-names>C</given-names></name>, <name><surname>Harjula</surname><given-names>S-KE</given-names></name>, <etal>et al</etal>
<article-title>Abnormal cerebellar development and ataxia in CARP VIII morphant zebrafish</article-title>. <source>Hum Mol Genet</source>. <year>2013</year>;<volume>22</volume>: <fpage>417</fpage>&#x2013;<lpage>432</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/hmg/dds438">10.1093/hmg/dds438</ext-link></comment>
<pub-id pub-id-type="pmid">23087022</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref077">
        <label>77</label>
        <mixed-citation publication-type="journal"><name><surname>Zanni</surname><given-names>G</given-names></name>, <name><surname>Cal&#xEC;</surname><given-names>T</given-names></name>, <name><surname>Kalscheuer</surname><given-names>VM</given-names></name>, <name><surname>Ottolini</surname><given-names>D</given-names></name>, <name><surname>Barresi</surname><given-names>S</given-names></name>, <name><surname>Lebrun</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Mutation of plasma membrane Ca<sup>2+</sup> ATPase isoform 3 in a family with X-linked congenital cerebellar ataxia impairs Ca<sup>2+</sup> homeostasis</article-title>. <source>Proc Natl Acad Sci USA</source>. <year>2012</year>;<volume>109</volume>: <fpage>14514</fpage>&#x2013;<lpage>14519</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1207488109">10.1073/pnas.1207488109</ext-link></comment>
<pub-id pub-id-type="pmid">22912398</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref078">
        <label>78</label>
        <mixed-citation publication-type="journal"><name><surname>Inagaki</surname><given-names>A</given-names></name>, <name><surname>Frank</surname><given-names>CA</given-names></name>, <name><surname>Usachev</surname><given-names>YM</given-names></name>, <name><surname>Benveniste</surname><given-names>M</given-names></name>, <name><surname>Lee</surname><given-names>A</given-names></name>. <article-title>Pharmacological correction of gating defects in the voltage-gated Ca<sub>V</sub>2.1 Ca<sup>2+</sup> channel due to a Familial Hemiplegic Migraine mutation</article-title>. <source>Neuron</source>. <year>2014</year>;<volume>81</volume>: <fpage>91</fpage>&#x2013;<lpage>102</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.neuron.2013.10.056">10.1016/j.neuron.2013.10.056</ext-link></comment>
<pub-id pub-id-type="pmid">24411734</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0146035.ref079">
        <label>79</label>
        <mixed-citation publication-type="journal"><name><surname>Pettersen</surname><given-names>EF</given-names></name>, <name><surname>Goddard</surname><given-names>TD</given-names></name>, <name><surname>Huang</surname><given-names>CC</given-names></name>, <name><surname>Couch</surname><given-names>GS</given-names></name>, <name><surname>Greenblatt</surname><given-names>DM</given-names></name>, <name><surname>Meng</surname><given-names>EC</given-names></name>, <etal>et al</etal>
<article-title>UCSF Chimera: a visualization system for exploratory research and analysis</article-title>. <source>J Comput Chem</source>. <year>2004</year>;<volume>25</volume>: <fpage>1605</fpage>&#x2013;<lpage>12</lpage>. <pub-id pub-id-type="pmid">15264254</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
